The DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index; 29 of the 137 sources its claims cite were checked for support.
Excess early mortality in schizophrenia.
Open accessAbstract
Schizophrenia is often referred to as one of the most severe mental disorders, primarily because of the very high mortality rates of those with the disorder. This article reviews the literature on excess early mortality in persons with schizophrenia and suggests reasons for the high mortality as well as possible ways to reduce it. Persons with schizophrenia have an exceptionally short life expectancy. High mortality is found in all age groups, resulting in a life expectancy of approximately 20 years below that of the general population. Evidence suggests that persons with schizophrenia may not have seen the same improvement in life expectancy as the general population during the past decades. Thus, the mortality gap not only persists but may actually have increased. The most urgent research agenda concerns primary candidates for modifiable risk factors contributing to this excess mortality, i.e., side effects of treatment and lifestyle factors, as well as sufficient prevention and treatment of physical comorbidity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
29 of 137 cited sources checked · 16 supported · 1 flagged · accuracy not yet measured
- Study design and conductcitation
Large differences exist between the effects achieved in the studies.
“Note that large differences exist between the effects achieved in the studies (Bonfioli et al. 2012, Caemmerer et al. 2012).”
- Also stated in: § Diet and Weight · plain
“Large differences exist between the effects achieved in the studies.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Bonfioli et al. 2012 source
In Results (‘Results for all interventions’; page unavailable), the paper says its test failed to suggest substantial heterogeneity in effects. Its ‘Heterogeneity of studies’ section describes differences in samples and interventions, but says the analysis did not detect statistically significant heterogeneity. Those differences do not establish the claimed large differences between effects. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites Caemmerer et al. 2012 source
- Also stated in: § Diet and Weight · plain
- Premisecitation
A UK study found life expectancy reduced by 14.6 years among persons with schizophrenia.
“A recent study from the United Kingdom (Chang et al. 2011) found that life expectancy was reduced by 14.6 years among persons with schizophrenia.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Chang et al. 2011 source
The Results report a 14.6-year reduction in life expectancy at birth for men with schizophrenia compared with national norms. The citing sentence omits that this figure applies to men; the reported reduction for women with schizophrenia was 9.8 years. (LLM, conf=0.93)
Experimental — accuracy not yet measured
- Premisecitation
A Welsh study found persons admitted with schizophrenia to an asylum from 1875 to 1924 died 10.8 years earlier than the general population.
“A Welsh study found that persons admitted with schizophrenia to an asylum from 1875 to 1924 died 10.8 years earlier than the general population (Healy et al. 2012).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Healy et al. 2012 source
The Population section identifies a North Wales asylum cohort admitted from 1875 to 1924. Results > Years of life lost reports 10.8 years lost for patients with schizophrenia whose deaths were confirmed, but 8.0 years when discharged patients were included. The citing sentence omits that qualification and presents 10.8 years as the figure for everyone admitted with schizophrenia. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
Some studies did not find a reduction in cardiovascular drug use in schizophrenia.
“However, some studies did not find a reduction in cardiovascular drug use (Desai et al. 2002, Plomondon et al. 2007).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Desai et al. 2002 source
- cites Plomondon et al. 2007 source
The Results report similar discharge prescription rates for aspirin, ACE-inhibitors/ARBs, and β-blockers in patients with and without severe mental illness. Schizophrenia was included in the severe-mental-illness group, but the reported medication comparison was for the pooled group, not for patients with schizophrenia separately. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
A British study found an MRR of 2 to 3.
“In the British study, an MRR of 2 to 3 was found.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brown et al. 2010 source
- Premisecitation
Underdiagnosis of somatic disorders in schizophrenic patients has been described in many studies.
“Underdiagnosis of somatic disorders in schizophrenic patients has been described in many other studies (Frayne et al. 2005, Laursen et al. 2009, Osborn et al. 2008).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites Frayne et al. 2005 source
- cites Laursen et al. 2009 source
- cites Osborn et al. 2008 source
The Discussion (Quality and variability of published studies; page unavailable) says people with severe mental illness may previously have been less likely to receive diabetes screening, which could underestimate recorded diabetes prevalence. That supports a possible detection gap, but not the broader claim that many studies have described underdiagnosis of somatic disorders specifically in patients with schizophrenia. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Moderate evidence suggests that it is possible to counteract weight loss or to prevent weight increases of 3.12 kg on average (or 0.94 kg/m2 measured as BMI) in obese mentally ill people undergoing antipsychotic treatment.
“Moderate evidence suggests that it is possible to counteract weight loss or to prevent weight increases of 3.12 kg on average (or 0.94 kg/m 2 measured as BMI) in obese mentally ill people undergoing antipsychotic treatment.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Bonfioli et al. 2012 source
The Discussion reports that lifestyle interventions reduced BMI by 0.98 kg/m², corresponding to 3.12% of initial weight—not 0.94 kg/m² or 3.12 kg. The Results describe participants taking antipsychotics, but the studies included normal-weight and overweight participants as well as obese participants. The paper reports reducing weight, not counteracting weight loss. Page numbers are not available in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites Caemmerer et al. 2012 source
The Results (Co-primary Outcomes; page not provided) report 3.12 kg less weight and 0.94 kg/m² less BMI with non-pharmacological interventions than with controls. The paper describes preventing or reducing weight gain, not “counteracting weight loss.” The claim also limits the finding to obese people, whereas the pooled groups’ mean BMIs were below the obesity threshold and the Discussion says significant benefits were found only in outpatient trials. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
One study has compared a specialized smoking cessation program for patients with schizophrenia with an ordinary program developed for people in the general population and found no differences in cessation rates between the two programs.
“No studies have compared smoking cessation programs with no intervention, but one study has compared a specialized smoking cessation program for patients with schizophrenia with an ordinary program developed for people in the general population and found no differences in cessation rates between the two programs (Baker et al. 2006).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Baker et al. 2006 source
The Study Design section says the trial compared a smoking cessation intervention for people with psychotic disorders against treatment as usual plus smoking-cessation booklets—not an ordinary cessation program developed for the general population. Overall Changes in Smoking reports no significant difference in abstinence rates between the randomized groups at 3, 6, or 12 months, supporting only the cessation-rate portion of the claim. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
Daumit et al. 2008 found treatment with olanzapine and quetiapine was associated with higher long-term risk of cardiovascular disease than treatment with perphenazin, risperidone, and ziprasidone.
“Daumit et al. (2008) analyzed changes in 10-year coronary heart disease risk estimates during the 18-month CATIE trial by antipsychotic treatment, and they found that treatment with olanzapine and quetiapine was associated with a higher long-term risk of cardiovascular disease than was treatment with perphenazin, risperidone, and ziprasidone.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Daumit et al. 2008 source
- Premisecitation
A study in age-dependent cognitive tests found a discrepancy of 20 years between persons with schizophrenia and the general population.
“A study in age-dependent cognitive tests found a discrepancy of 20 years between persons with schizophrenia and the general population (Fernandez-Egea et al. 2011), in accordance with the 20 years' shorter life expectancy.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Fernandez-Egea et al. 2011 source
The Introduction describes a hypothesis of accelerated aging in schizophrenia, but the Methods and Results examine testosterone activity, not age-dependent cognitive tests. Neither the supplied passages nor searches for cognitive tests and a 20-year difference found the claimed comparison with the general population in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Previous studies indicate that excess mortality (whether caused by disease or external factors) peaks during the first year after patients are discharged from the hospital.
“Previous studies indicate that excess mortality (whether caused by disease or external factors) peaks during the first year after patients are discharged from the hospital (Nordentoft et al. 2013), which has been previously documented for suicide (Nordentoft et al. 2004;Osby et al. 2000Osby et al. , 2001)).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Nordentoft et al. 2013 source
- Findingcitation
A recent study using the entire population in Denmark, Sweden, and Finland found life expectancies 15.6 to 20 years shorter in persons with psychiatric hospital admission for schizophrenia.
“A recent study using information from the entire population in Denmark, Sweden, and Finland calculated life expectancy among the general population and compared it to persons with a psychiatric hospital admission for a diagnosis of schizophrenia and found life expectancies to be 15.6 to 20 years shorter in this patient group in these three countries”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2013b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
New nationwide Danish data show that obesity, smoking, unhealthy diet, and sedentary behavior are seen approximately twice as frequently in people who self-report that they have a mental illness as compared with the general population.
“New nationwide Danish data show that obesity, smoking, unhealthy diet, and sedentary behavior are seen approximately twice as frequently in people who self-report that they have a mental illness as compared with the general population.”
Quote in the paperNot a substantial claim - Findingnone given
Our results indicate that people with mental illness have the same interest as control groups do in changing their lifestyle with regard to smoking, diet, and physical activity.
“Our results indicate that people with mental illness have the same interest as control groups do in changing their lifestyle with regard to smoking, diet, and physical activity.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Persons with schizophrenia may not have seen the same improvement in life expectancy as the general population during past decades.
“Evidence suggests that persons with schizophrenia may not have seen the same improvement in life expectancy as the general population during the past decades.”
Quote in the paperSubstantial claim - Interpretationreasoning
Persons with schizophrenia have an exceptionally short life expectancy.
“Persons with schizophrenia have an exceptionally short life expectancy.”
Quote in the paperSubstantial claim - Premisecitation
A Finnish study including only persons with schizophrenia older than 65 found SMR 2.69.
“Another Finnish study that included only persons with schizophrenia older than 65 found a SMR of 2.69 (Talaslahti et al. 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Talaslahti et al. 2012 source
- Study design and conductreasoning
The extremely high MRR in young age groups should be interpreted with caution because of the very low number of deaths in the general population.
“The extremely high MRR in the young age groups should be interpreted with caution because of the very low number of deaths in the general population.”
Quote in the paperSubstantial claim - Premisecitation
A Finnish study found life expectancy 10 to 15 years shorter for persons with diagnosis in the schizophrenia spectrum.
“A Finnish study found life expectancy to be 10 to 15 years shorter for persons with a diagnosis in the schizophrenia spectrum (Westman et al. 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Westman et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisereasoning
The MRR/SMR between persons with schizophrenia and the general population decreases with increasing age (effect modification by age).
“Since the time that Odegard (1951) and Alstr öm (1942) conducted studies, the MRR (or SMR) between persons with schizophrenia and the general population has been shown to decrease with increasing age.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Odegard (1951)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Alström (1942)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Brown 1997 meta-analysis found SMR in schizophrenia 1.51, i.e., mortality rate on average 51% higher than the general population.
“The SMR in persons with schizophrenia was found to be 1.51, i.e., the mortality rate was on average 51% higher than that of the general population.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brown 1997 source
- Premisecitation
A Swedish study found excess mortality in patients admitted with schizophrenia 2.8 for men and 2.4 for women.
“In a study from Sweden (Osby et al. 2000), the excess mortality in patients who had been admitted with schizophrenia was 2.8 for men and 2.4 for women.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Osby et al. 2000 source
- Premisecitation
A study focusing on patients with schizophrenia and substance abuse found age at death particularly low (49 years).
“A study focusing on patients with schizophrenia and substance abuse, i.e., a dual diagnosis (Schmidt et al. 2011), found that age at death for these patients was particularly low (49 years).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schmidt et al. 2011 source
- Premisecitation
A Finnish study found excess mortality in schizophrenic patients 3.3 for men and 2.3 for women.
“In a Finnish study ( Joukamaa et al. 2001), the excess mortality in schizophrenic patients was 3.3 for men and 2.3 for women.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Joukamaa et al. 2001 source
- Interpretationreasoning
The explanation for effect modification by age is that mortality in the general population is very low in young age groups.
“The explanation for the effect modification by age is that the mortality in the general population is very low in the young age groups.”
Quote in the paperSubstantial claim - Premisecitation
A Danish study found a person with schizophrenia died 11.2 years earlier than the general population.
“A Danish study used age at death among persons with schizophrenia as an indication of length of life expectancy compared to the general population and found that a person with schizophrenia died 11.2 years earlier than the general population (Nielsen et al. 2013b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nielsen et al. 2013b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Lower MRRs among 18-19-year-olds compared to 20-36-year-olds probably appears because young men from the general population are more often involved in traffic accidents than young men with schizophrenia.
“For example, the lower MRRs among the 18-to 19-year-olds (compared to the 20-to 36-year-olds) probably appears because young men from the general population are more often involved in traffic accidents than are young men with schizophrenia.”
Quote in the paperNot a substantial claim - Premisecitation
SMRs for schizophrenia increased significantly during the seventies, eighties, and nineties: from 1.84 to 2.98 to 3.20.
“Another interesting result was that the SMRs increased significantly during three recent decades, i.e., the seventies, eighties, and nineties; from 1.84, to 2.98, to 3.20, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Saha et al. 2007 source
- Premisecitation
Most of the excess mortality in schizophrenia is explained by natural causes of death.
“However, mounting evidence suggests that most of the excess mortality is explained by natural causes of death (Laursen 2011)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
SMR for cancer in schizophrenia was only 1.37.
“Notably, the SMR for cancer was only 1.37, which has also been observed in other studies (Laursen et al. 2007;Mortensen & Juel 1990, 1993).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Laursen et al. 2007 source
- cites Mortensen & Juel 1990, 1993
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
An Israeli study found life expectancy 12 years lower among persons with schizophrenia.
“A study from Israel found life expectancy to be 12 years lower among persons with schizophrenia (Kodesh et al. 2012)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kodesh et al. 2012 source
- Premisecitation
A Finnish study found life expectancy at age 20 was 25 years shorter in 1996 and 22.5 years shorter in 2006.
“An even shorter life expectancy was found during 11 years of follow-up in a Finnish study; life expectancy at age 20 was found to be 25 years shorter in 1996 and 22.5 years shorter in 2006 (Tiihonen et al. 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tiihonen et al. 2009 source
- Interpretationreasoning
The overall improvement in cardiovascular treatment and lifestyle experienced by the general population has not been experienced by persons with schizophrenia.
“The study suggests that the overall improvement in cardiovascular treatment and lifestyle experienced by the general population has not been experienced by persons with schizophrenia.”
Quote in the paperSubstantial claim - Premisecitation
A Swedish study found persons with schizophrenia died 15 years (men) and 12 years (women) earlier than the general population.
“The same method was used in a study from Sweden that found that persons with schizophrenia died 15 years (men) and 12 years (women) earlier than the general population (Crump et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Crump et al. 2013 source
- Interpretationcitation
Studies indicate that lives of persons with schizophrenia are between 10 and 25 years shorter than those of the general population.
“With that caution in mind, studies indicate that the lives of persons with schizophrenia are between 10 and 25 years shorter than those of the general population.”
Quote in the paperSubstantial claim - Premisecitation
A higher prevalence of chronic medical conditions among patients with psychotic disorders has been shown in the United States.
“Furthermore, a higher prevalence of chronic medical conditions among patients with psychotic disorders has been shown in the United States (Carney et al. 2006, Carney & Jones 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Carney et al. 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Carney & Jones 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
A consistent finding is a negative relationship between schizophrenia and autoimmune diseases.
“A consistent finding is the negative relationship between schizophrenia and autoimmune diseases.”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Rheumatoid arthritis has a negative correlation with schizophrenia.
“Rheumatoid arthritis in particular has been shown to have a negative correlation with schizophrenia (Eaton et al. 1992(Eaton et al. , 2006;;Oken & Schulzer 1999).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
A Danish study showed rheumatoid arthritis was the only somatic disorder (out of 19 common chronic somatic disorders) with a lower rate in persons with schizophrenia.
“A Danish study showed that rheumatoid arthritis was the only somatic disorder (out of 19 common chronic somatic disorders) with a lower rate in persons with schizophrenia (Laursen et al. 2011)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Laursen et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Evidence suggests antipsychotics are responsible for some of the excess mortality among persons with schizophrenia, especially since introduction in the late 1990s of second-generation antipsychotics.
“Evidence has suggested that antipsychotics are responsible for some of the excess mortality among persons with schizophrenia, especially since the introduction in the late 1990s of second-generation antipsychotics (Saha et al. 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Saha et al. 2007 source
- Premisecitation
A study from Africa found higher mortality among all patients at a Nigerian psychiatric hospital.
“Finally, a study from Africa found higher mortality among all patients at a Nigerian psychiatric hospital (Abiodun 1988).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abiodun 1988 source
- Premisecitation
A Finnish study found that difference in mortality among women with schizophrenia compared to the general population has diminished during recent years.
“In contrast, a study from Finland (Westman et al. 2011) found that the difference in mortality among women with schizophrenia compared to the general population has diminished during recent years.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Westman et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Another Danish study found individuals with schizophrenia had a highly reduced risk for being admitted to hospital with rheumatoid arthritis [odds ratio 0.44 (CI 0.24-0.81)].
“and another Danish study also found that individuals with schizophrenia had a highly reduced risk for being admitted to a hospital with rheumatoid arthritis [odds ratio 0.44 (CI 0.24-0.81)].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mors et al. 1999 source
- Premisecitation
A Danish study found reduced use of nearly all cardiac drugs in schizophrenia.
“A study from Denmark (Laursen et al. 2013a) also found reduced use of nearly all cardiac drugs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Laursen et al. 2013a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Briskman et al. 2012 found comorbid somatic disorders (diabetes, hypertension, dyslipidemia) were underdiagnosed and undertreated in patients with co-occurring schizophrenia.
“They found that comorbid somatic disorders, e.g., diabetes, hypertension, and dyslipidemia, were underdiagnosed and undertreated in the patients with co-occurring schizophrenia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Briskman et al. 2012 source
- Premisecitation
A Danish study showed excess incidence in persons with schizophrenia in all but one of the somatic disorders from the Charlson index.
“A Danish study showed excess incidence in persons with schizophrenia in all but one of the somatic disorders from the Charlson index (Laursen et al. 2011)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Laursen et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
In conclusion, mortality among persons with schizophrenia is between two and three times higher than the general population when all age groups are included.
“In conclusion, the mortality among persons with schizophrenia is between two and three times higher than that of the general population when all age groups are included.”
Quote in the paperSubstantial claim - Premisecitation
Studies from Australia and Canada report higher levels of somatic admissions in individuals with schizophrenia compared to the general population.
“Studies from Australia and Canada also report higher levels of somatic admissions in individuals with schizophrenia compared to the general population (Kisely et al. 2007, Lawrence et al. 2003).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
No evidence suggested that risk varied by type of antipsychotic drugs.
“However, no evidence suggested that the risk varied by type of antipsychotic drugs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Raedler 2010 source
- Premisecitation
Risk factors for cardiovascular disorders are more common in patients with severe mental disorders than in patients without such disorders.
“Several studies have found that risk factors for cardiovascular disorders were more common in patients with severe mental disorders (Birkenaes et al. 2007, Newcomer & Hennekens 2007) than in patients without such disorders.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Antipsychotic medicine may have negative side effects.
“Antipsychotic medicine may have negative side effects.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2012 source
- Premisecitation
The extent of heavy smoking (more than 15 cigarettes daily) among people with long-lasting mental disorder was 25.9% versus 10.1% for those without such disorder.
“The extent of heavy smoking (more than 15 cigarettes daily) among people with long-lasting mental disorder was 25.9% versus 10.1% for those without such disorder.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nordentoft et al. 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductcitation
38% of participants were excluded from the Dutch study because they had less than 50% attendance.
“However, 38% of participants were excluded from the study because they had less than 50% attendance.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scheewe et al. 2012 source
- Premisecitation
Weight management programs have proven to be effective in preventing weight increase (or weight loss) during treatment with antipsychotic medication.
“However, weight management programs have proven to be effective in preventing weight increase (or weight loss) during treatment with antipsychotic medication.”
Quote in the paperNot a substantial claim - Premisecitation
Goff et al. 2005 compared CATIE patients with matched controls and found higher risk of cardiovascular disease among patients.
“Goff et al. (2005) compared patients with schizophrenia included in the Clinical Trials of Antipsychotic Treatment Effectiveness (CATIE) study with matched controls and found a higher risk of cardiovascular disease among the patients.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Goff et al. 2005 source
- Premisecitation
A recent meta-analysis based on FDA data from placebo-controlled studies found antipsychotic medication did not increase risk of death from diseases and medical conditions.
“In a recent meta-analysis based on FDA data from placebo-controlled studies, the investigators found, contrary to their expectation, that antipsychotic medication did not increase the risk of death from diseases and medical conditions (Khan et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Khan et al. 2013 source
- Premisecitation
In a systematic review, Compton et al. (2006) concluded that people with mental disorders belonging to different diagnostic groups in the United States were twice as likely to be smokers.
“In a systematic review, Compton et al. (2006) concluded that people with mental disorders belonging to different diagnostic groups in the United States were twice as likely to be smokers.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Compton et al. 2006 source
- Premisecitation
Beebe et al. (2005) found a nonsignificant decline of 1.27 kg/m2 in body mass index (BMI) in the training group versus 0.14 kg/m2 in the control group.
“Beebe et al. (2005) found a nonsignificant decline of 1.27 kg/m 2 in body mass index (BMI) in the training group versus 0.14 kg/m 2 in the control group.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Beebe et al. 2005 source
- Premisecitation
A Cochrane review based on 11 trials including 685 daily smokers with schizophrenia concluded that bupropion improved the chances of quitting smoking by 2.8 fold (95% CI: 1.02-7.58).
“A Cochrane review based on 11 trials including 685 daily smokers with schizophrenia (Tsoi et al. 2013) concluded that bupropion improved the chances of quitting smoking by 2.8 fold (95% CI: 1.02-7.58).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tsoi et al. 2013 source
- Premisecitation
Surveys indicate that smoking occurs more frequently among people with schizophrenia than in the general population.
“surveys indicate that smoking occurs more frequently among people with schizophrenia than in the general population.”
Quote in the paperSubstantial claim - Interpretationreasoning
Smoking is one of the risk factors most likely to contribute substantially to reduced life expectancy in schizophrenia.
“One of the risk factors most likely to contribute substantially to reduced life expectancy in schizophrenia is smoking.”
Quote in the paperSubstantial claim - Premisecitation
Meta-analyses that were based on more sophisticated statistical methods and included large long-term follow-up studies found lower figures.
“Meta-analyses that were based on more sophisticated statistical methods and included large long-term follow-up studies found lower figures (Bostwick & Pankratz 2000, Inskip et al. 1998, Palmer et al. 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisereasoning
Smoking cessation programs and nicotine substitution seem to support smoking cessation among people with schizophrenia.
“Smoking cessation programs and nicotine substitution seem to support smoking cessation among people with schizophrenia.”
Quote in the paperSubstantial claim - Premisecitation
A large study from Spain found that 55% of nearly 2,000 outpatients with schizophrenia were smokers.
“A large study from Spain found that 55% of nearly 2,000 outpatients with schizophrenia were smokers (Bobes et al. 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bobes et al. 2010 source
- Premisecitation
Another Danish survey carried out among users of drop-in centers or institutions for people who were homeless showed that 80% of people with mental disorders in this population were daily smokers.
“Another Danish survey carried out among users of drop-in centers or institutions for people who were homeless showed that 80% of people with mental disorders in this population were daily smokers (Pedersen et al. 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pedersen et al. 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Skrinar et al. (2005) found a nonsignificant decline in BMI of 0.7 kg/m2 versus an increase of 0.5 kg/m2 in the control group.
“Skrinar et al. (2005) found a nonsignificant decline in BMI of 0.7 kg/m 2 versus an increase of 0.5 kg/m 2 in the control group.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Skrinar et al. 2005 source
- Premisereasoning
Data also indicate that it is possible to maintain a weight loss after completion of the intervention since the achieved weight loss is still significant after 3.6 months.
“Data also indicate that it is possible to maintain a weight loss after completion of the intervention since the achieved weight loss is still significant after 3.6 months.”
Quote in the paperNot a substantial claim - Study design and conductnone given
A modest dropout rate is found in the lifestyle intervention groups that focus on weight loss or weight stability compared with the control groups (15% versus 17%).
“A modest dropout rate is found in the lifestyle intervention groups that focus on weight loss or weight stability compared with the control groups (15% versus 17%).”
Quote in the paperNot a substantial claim - Premisecitation
In the American CATIE study, 58% of the included patients with schizophrenia were smokers.
“In the American CATIE study, 58% of the included patients with schizophrenia were smokers (Daumit 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Daumit 2008
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Only weak evidence supports the theory that participation in training programs will lead to weight loss among people suffering from schizophrenia.
“Thus, only weak evidence supports the theory that participation in training programs will lead to weight loss among people suffering from schizophrenia.”
Quote in the paperSubstantial claim - Premisecitation
Laursen et al. (2005) have documented an excess mortality in the parents of patients with schizophrenia.
“Laursen et al. (2005) have documented an excess mortality in the parents of patients with schizophrenia, a finding that could suggest both shared environmental and genetic factors but may also reflect an impact of the stress associated with caring for a severely ill family member.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Laursen et al. 2005 source
- Premiseown data
In addition to the effect on weight, significant changes have been found in other clinically relevant somatic risk factors, including the levels of body fat percentage, fasting plasma glucose, and blood fat.
“In addition to the effect on weight, significant changes have been found in other clinically relevant somatic risk factors, including the levels of body fat percentage, fasting plasma glucose, and blood fat.”
Quote in the paperNot a substantial claim - Premisecitation
Fetal growth restriction has been associated with both schizophrenia and multiple somatic health outcomes.
“Shared environmental risk factors affecting fetal development may also contribute to the excess mortality, as fetal growth restriction has been associated with both schizophrenia (Nielsen et al. 2013a) and multiple somatic health outcomes (Risnes et al. 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Nielsen et al. 2013a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Risnes et al. 2011 source
- Premisecitation
The general socioeconomic background is also strongly related to mortality gradients, even in Scandinavian countries with relatively modest socioeconomic differences and universal access to free health care.
“The general socioeconomic background is also strongly related to mortality gradients, even in Scandinavian countries with relatively modest socioeconomic differences and universal access to free health care (Diderichsen et al. 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Diderichsen et al. 2012 source
- Interpretationown data
We find moderate evidence that it is possible to take actions leading to weight loss or prevention of weight increases of an average of 3.12 kg or a BMI equaling 0.94 kg/m2 in obese mentally ill people undergoing antipsychotic treatment.
“We find moderate evidence that it is possible to take actions leading to weight loss or prevention of weight increases of an average of 3.12 kg or a BMI equaling 0.94 kg/m 2 in obese mentally ill people undergoing antipsychotic treatment.”
Quote in the paperSubstantial claim - Premisecitation
The co-occurrence of deliberate self-harm increased the risk approximately twofold.
“The co-occurrence of deliberate self-harm increased the risk approximately twofold (Nordentoft et al. 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nordentoft et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The European guidelines for prevention of cardiovascular disease primarily target older people because individuals under the age of 50 have a very low risk of cardiovascular morbidity and mortality.
“The European guidelines for prevention of cardiovascular disease primarily target older people because individuals under the age of 50 have a very low risk of cardiovascular morbidity and mortality (Perk et al. 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Perk et al. 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
If behavioral mood management therapy is included, smoking cessation counseling increases the chance of smoking cessation by approximately 1.5 times compared with no counseling.
“If behavioral mood management therapy is included, smoking cessation counseling increases the chance of smoking cessation by approximately 1.5 times compared with no counseling.”
Quote in the paperNot a substantial claim - Premisecitation
The documentation of excess mortality from tuberculosis among psychiatric patients helped introduce specific interventions and treatment facilities that contributed to the reduction of this major source of excess mortality.
“There seems to be a historical parallel between now and 70 years ago, when the documentation of excess mortality from tuberculosis among psychiatric patients (Alstrøm 1942) helped introduce specific interventions and treatment facilities that contributed to the reduction of this major source of excess mortality.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Alstrøm 1942
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
Moderate evidence also suggests that counseling to help quit smoking works for people with previous or ongoing depression.
“Moderate evidence also suggests that counseling to help quit smoking works for people with previous or ongoing depression.”
Quote in the paperNot a substantial claim - Premisecitation
Nordentoft et al. (2011) found the absolute risk of suicide in schizophrenia to be 6.55% (95% CI: 5.85-7.34) among men and 4.91% (95% CI: 4.03-5.98) among women.
“In an analysis of the absolute risk of suicide in a total national cohort of 176,347 individuals, who were followed from first psychiatric contact up to 36 years after first psychiatric contact, Nordentoft et al. (2011) found the absolute risk of suicide in schizophrenia to be 6.55% (95% CI: 5.85-7.34)among men and 4.91% (95% CI: 4.03-5.98)among women.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nordentoft et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
The steepest increase in suicide risk occurs during the first few years after initial contact with mental health services.
“The steepest increase in suicide risk occurs during the first few years after initial contact with mental health services; thus, early intensive intervention initiatives are needed.”
Quote in the paperNot a substantial claim - Interpretationcitation
The risk of suicide is high in schizophrenia.
“It is beyond doubt that the risk of suicide is high in schizophrenia, and suicide preventive measures should be a mandatory part of treatment programs (Hawton & Saunders 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hawton & Saunders 2009 source
- Premisecitation
Patients with psychiatric disorders receive less treatment for physical conditions than do people without psychiatric disorders.
“This interpretation is supported by studies documenting that patients with psychiatric disorders receive less treatment for physical conditions than do people without psychiatric disorders (Kisely et al. 2009, Laursen et al. 2009, Lawrence et al. 2000).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisenone given
Cardiovascular morbidity and mortality in schizophrenia often occur before age 50.
“Cardiovascular morbidity and mortality in schizophrenia often occur before age 50.”
Quote in the paperNot a substantial claim - Premisecitation
A history of deliberate self-harm markedly increases the risk of suicide in schizophrenia and other diagnostic groups.
“It is also evident that a history of deliberate self-harm markedly increases the risk of suicide in schizophrenia and other diagnostic groups (Nordentoft et al. 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nordentoft et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductown data
We find a modest dropout rate in the lifestyle interventions that focus on weight loss or weight stability compared with the control groups (15% versus 17%).
“We find a modest dropout rate in the lifestyle interventions that focus on weight loss or weight stability compared with the control groups (15% versus 17%).”
Quote in the paperNot a substantial claim - Interpretationnone given
The excess risk of suicide contributes to the shorter life expectancy in patients with schizophrenia.
“It is well known that the excess risk of suicide contributes to the shorter life expectancy in patients with schizophrenia.”
Quote in the paperNot a substantial claim - Premiseown data
Some data also indicate that it is possible for participants to maintain a weight loss after completion of the intervention since the achieved weight loss was still significant after 3.6 months.
“Some data also indicate that it is possible for participants to maintain a weight loss after completion of the intervention since the achieved weight loss was still significant after 3.6 months.”
Quote in the paperNot a substantial claim - Interpretationnone given
Evidence suggests that persons with schizophrenia may not have experienced the same improvement in life expectancy as the general population has during the past decades.
“Not only do persons with schizophrenia have a short life expectancy, but evidence also suggests that they may not have experienced the same improvement in life expectancy as the general population has during the past decades.”
Quote in the paperSubstantial claim
- It may state two separate claims as one. 69
- The quote only partly states this claim. 1
- Probably not a substantial claim. 56
It may state two separate claims as one. The quote only partly states this claim.
PremisecitationSchizophrenia is one of the most severe and disabling disorders worldwide, primarily because of very high mortality rates.
“Schizophrenia is often referred to as one of the most severe mental disorders, primarily because of the very high mortality rates of those with the disorder.”
- Also stated in: § INTRODUCTION · hedged
“the data nevertheless indicate that schizophrenia is one of the most severe and disabling disorders worldwide.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Salomon et al. 2012 source
The Results (page not provided) identify acute schizophrenia as one of the health states with the highest disability weights, supporting the severity aspect of the claim. They do not say that schizophrenia has very high mortality rates or that mortality is the primary reason for its severity; the paper’s mortality comparison concerns disability weights generally. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Also stated in: § INTRODUCTION · hedged
It may state two separate claims as one.
PremisecitationThe same widening of the mortality gap was found in another Danish study and in a UK study.
“The same widening of the mortality gap was found in another Danish study (Nielsen et al. 2013b) and in a study from the United Kingdom (Brown et al. 2010).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Nielsen et al. 2013b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Brown et al. 2010 source
The Results (Time trends in mortality; page unavailable) show a rise in cardiovascular mortality relative to the general population, but the trend was of borderline statistical significance. The all-cause mortality ratio changed only slightly and not significantly (P=0.6), so the paper does not establish the unqualified widening of the mortality gap attributed to the UK study. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationSaha et al. systematic review found lifetime morbidity risk of schizophrenia 7.2 per 1,000 persons, with 10% and 90% quantiles 3.1 and 27.1, and huge difference across studies.
“A systematic review by Saha et al. (2005) found a lifetime morbidity risk of 7.2 per 1,000 persons; the 10% and 90% quantiles were 3.1 and 27.1, respectively.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Saha et al. 2005 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationIn a large worldwide study, 220 disorders were assigned disability weights; schizophrenia in an acute state had a score of 0.76, the most severe of all 220.
“However, the most severe of all 220 disorders was schizophrenia in an acute state, with a score of 0.76.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Salomon et al. 2012 source
The Findings report that acute schizophrenia had the highest disability weight, 0.76, among the 220 assessed. However, the paper calls these 220 entities health states, not 220 distinct disorders; the Results note that a single disorder could have multiple severity states. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationImmigrants have a higher incidence of schizophrenia.
“as do immigrants (Cantor-Graae et al. 2003).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Cantor-Graae et al. 2003 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationLawrence et al. 2010 concluded insufficient health service for schizophrenic patients with cardiovascular disease may explain part of increased mortality from natural causes.
“Lawrence et al. (2010) concluded that insufficient health service for schizophrenic patients with cardiovascular disease may explain part of the increased mortality from natural causes.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Lawrence et al. 2010 source
Probably not a substantial claim.
PremisecitationMitchell & Lord 2010 concluded evidence supports that deficits in quality of care contribute to higher-than-expected mortality in people with schizophrenia.
“Mitchell & Lord (2010) reviewed papers on invasive cardiac procedures and medication and concluded that evidence supports that deficits in quality of care contribute to higher-than-expected mortality in people with schizophrenia.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Mitchell & Lord 2010 source
It may state two separate claims as one.
PremisecitationTwo meta-analyses indicated that weight management programs could impede weight gain during antipsychotic treatment and could also be effective for weight loss.
“Two meta-analyses (Bonfioli et al. 2012, Caemmerer et al. 2012) indicated that weight management programs could impede weight gain during antipsychotic treatment and could also be effective for weight loss.”
Quote in the paperNot a substantial claim2 of 2 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationDaumit et al. (2013) found further support in a randomized controlled trial for weight loss through weight management programs.
“After the publication of the meta-analyses (Bonfioli et al. 2012, Caemmerer et al. 2012), Daumit et al. (2013) found further support in a randomized controlled trial for weight loss through weight management programs.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Daumit et al. 2013 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
InterpretationcitationSuicide attempt should be considered a very important risk factor among patients with schizophrenia and other mental disorders.
“In addition, suicide attempt should be considered a very important risk factor among patients with schizophrenia and other mental disorders, as underlined by the recent findings in a large Swedish study (Runeson et al. 2010).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Runeson et al. 2010 source
Probably not a substantial claim.
PremisecitationAccording to the theory of accelerated aging, physiological changes associated with aging occur at an earlier age in people with schizophrenia compared to the general population.
“According to this theory, physiological changes associated with aging occur at an earlier age in people with schizophrenia compared to the general population (Kirkpatrick et al. 2008).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Kirkpatrick et al. 2008 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationDutta et al. (2010) estimated a lifetime risk of suicide of 3.23% for patients 20 years after the first psychotic diagnosis.
“Recently, Dutta et al. (2010) estimated a lifetime risk of suicide of 3.23% for patients 20 years after the first psychotic diagnosis.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Dutta et al. 2010 source
Table 4 reports a 3.23% cumulative suicide risk for the entire cohort at 20 years after the first psychotic episode. It does not establish 3.23% as a lifetime risk: the paper cautions about that term, and its Results report suicides after 20 years of follow-up. The study measures time from first presentation or episode, rather than first diagnosis. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAn alternative explanation of the early excess mortality in persons with schizophrenia has been the theory of accelerated aging.
“An alternative explanation of the early excess mortality in persons with schizophrenia has been the theory of accelerated aging.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Kirkpatrick et al. 2008 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe American Schizophrenia Patient Outcomes Research Team recommends weight management for patients with schizophrenia and a BMI higher than 25.
“The American Schizophrenia Patient Outcomes Research Team recommends weight management for patients with schizophrenia and a BMI higher than 25 (Dixon et al. 2010); however, it is not clear how these weight management programs should be administered.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Dixon et al. 2010 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationDaumit et al. (2013) report a 3.2 kg weight loss in a randomized controlled trial that examines the outcome of a tailored weight management program versus standard treatment in a group of patients with schizophrenia and other severe mental disorders and with a mean body mass index of 36.3 kg/m2.
“A similar approach focusing on obesity has been evaluated by Daumit et al. (2013), who report a 3.2 kg weight loss in a randomized controlled trial that examines the outcome of a tailored weight management program versus standard treatment in a group of patients with schizophrenia and other severe mental disorders and with a mean body mass index of 36.3 kg/m 2 .”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Daumit et al. 2013 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataApproximately 1.5% of the Danish population will get a diagnosis of schizophrenia at some point in life.
“From Danish population registries, we know that approximately 1.5% of the population will get a diagnosis of schizophrenia at some point”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Thorup et al. 2007 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Findingown dataIn Denmark, incidence of schizophrenia peaks in the late teens and early twenties and is more pronounced among males than females.
“A sharp peak occurs in the late teens and early twenties and is more pronounced among males than females.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataIn Denmark, incidence of schizophrenia declines steadily after age 22, and at age 60-61 is 0.1 new cases per 1,000 years under risk in both men and women.
“The incidence declines steadily after the age of 22, and at the maximum age of this cohort, 60 to 61 years, the incidence is 0.1 new cases of schizophrenia per 1,000 years under risk in both men and women.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataThe data also show that these individuals want to stop smoking, eat more healthily, and be more physically active just as much as the general population does.
“However, the data also show that these individuals want to stop smoking, eat more healthily, and be more physically active just as much as the general population does.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingnone givenThey associate better health with a more meaningful daily life and better quality of life.
“They associate better health with a more meaningful daily life and better quality of life.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingnone givenThe most significant barriers to changing their lifestyle are the symptoms of the mental illness and the adverse drug effects of medical treatment, but individuals with mental illness are also challenged by a life situation characterized by social isolation and difficulties with creating a structured life.
“The most significant barriers to changing their lifestyle are the symptoms of the mental illness and the adverse drug effects of medical treatment, but individuals with mental illness are also challenged by a life situation characterized by social isolation and difficulties with creating a structured life.”
Quote in the paperSubstantial claimProbably not a substantial claim.
Findingnone givenMortality rate ratio for persons with schizophrenia in Denmark compared to the general population.
“Mortality rate ratio for persons with schizophrenia (solid line) in Denmark compared to the general population (reference group; dotted line).”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingnone givenIncidence of schizophrenia among women and men, ages 13 to 60, per 1,000 years under risk in Denmark in the period 1995 to 2011.
“Incidence of schizophrenia among women (solid line) and men (dotted line), ages 13 to 60, per 1,000 years under risk in Denmark in the period 1995 to 2011.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
Findingnone givenIncidence rate ratios of 19 somatic chronic diseases included in the Charlson Comorbidity Index among persons previously admitted with schizophrenia to a Danish psychiatric hospital compared to the general population without psychiatric hospital contact.
“Incidence rate ratios of 19 somatic chronic diseases included in the Charlson Comorbidity Index among persons previously admitted with schizophrenia to a Danish psychiatric hospital compared to the general population without psychiatric hospital contact.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
InterpretationreasoningThe mortality gap in schizophrenia not only persists but may actually have increased.
“Thus, the mortality gap not only persists but may actually have increased.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
InterpretationcitationHigh mortality in schizophrenia is found in all age groups, resulting in life expectancy approximately 20 years below that of the general population.
“High mortality is found in all age groups, resulting in a life expectancy of approximately 20 years below that of the general population.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationHarris & Barraclough review documented excess mortality among psychiatric patients, especially patients with schizophrenia.
“A cornerstone study was the extensive review by Harris & Barraclough (1998), which documented excess mortality among psychiatric patients, especially patients with schizophrenia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Harris & Barraclough (1998) source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationSchizophrenia occurs worldwide.
“schizophrenia occurs worldwide (McGrath et al. 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites McGrath et al. 2008 source
Probably not a substantial claim. It may state two separate claims as one.
Study design and conductreasoningSome studies use only information on persons with schizophrenia who died, so results should be interpreted with caution.
“However, some of the studies use only information on the persons with schizophrenia who died, and results should therefore be interpreted with caution.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationCause-specific SMRs for schizophrenia were higher than 1 except for cerebrovascular disease, which was based on only three studies.
“An elevated mortality rate among persons with schizophrenia was indicated by cause-specific SMRs that were higher than 1, except for the SMR for cerebrovascular disease, which was based on only three studies.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Saha et al. 2007 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
InterpretationreasoningThe incidence of schizophrenia varies significantly across different groups within a population and between countries.
“The overall picture is that the incidence of schizophrenia varies significantly not only across different groups within a population but also between countries.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
InterpretationcitationResults from Denmark are similar to those of studies from other countries, although some differences are noted.
“The results from Denmark are similar to those of studies from other countries, although some differences are noted.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Interpretationnone givenMore than 1% of a population has schizophrenia.
“Although it is not a common disorder, more than 1% of a population has schizophrenia.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationPrognosis and outcome in persons with schizophrenia tended to be worse, including higher mortality rates, than in persons with bipolar disorder.
“The prognosis and outcome in persons with schizophrenia tended to be worse (including higher mortality rates) than the outcome in persons with bipolar disorder (Shorter 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shorter 1997
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationKraepelin's dichotomization proved later not to be entirely true because some patients with schizophrenia recovered completely.
“Kraepelin's dichotomization proved later not to be entirely true because some patients with schizophrenia recovered completely”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Angst 2002 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductreasoningCalculating excess mortality as differences in years lived compared to the general population presents advantages: it takes into account common causes of death with low excess mortality, gives more weight to deaths among younger persons, and presents a straightforward measure.
“These advantages include that the method takes into account the effect of very common causes of death with relatively low excess mortality, it gives more weight to deaths occurring among younger persons (which are more common among persons with severe mental disorders than the general population), and it presents a straightforward and understandable measure of the magnitude of the excess mortality”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationMore than 60 years ago, Odegard showed excess mortality in patients admitted to a Norwegian mental hospital from 1926 to 1941; mortality rate for men with schizophrenia was 3.2 times higher than the general Norwegian population, and for women 4.8.
“The mortality rate for men with schizophrenia was 3.2 times higher than that for the general Norwegian population, and the corresponding number for women was 4.8.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Odegard (1951)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationPersons living and/or born in the city have a higher incidence of schizophrenia.
“persons living and/or born in the city have a higher incidence (Pedersen & Mortensen 2006)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pedersen & Mortensen 2006 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationMales have a higher incidence of schizophrenia and an earlier onset than females.
“males have a higher incidence of schizophrenia, males have an earlier onset (van der Werf et al. 2012)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van der Werf et al. 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationSaha et al. 2007 systematic review of 37 studies found overall SMR 2.58, with 10% and 90% quantiles 1.18 and 5.76.
“The overall SMR was 2.58, with 10% and 90% quantiles of 1.18 and 5.76, respectively.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Saha et al. 2007 source
It may state two separate claims as one.
PremisecitationThe cardiovascular mortality gap between persons with schizophrenia and the general population has grown; a Danish register-based study found MRR increased from around 2.0 in 1994 to 3.5 in 2006.
“The cardiovascular mortality gap between persons with schizophrenia and the general population has also grown during the past few decades, according to a Danish register-based study (Laursen & Nordentoft 2011); the mortality rate ratio has increased from around 2.0 in 1994 to 3.5 in 2006 compared to the general population.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen & Nordentoft 2011 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe risk of suicide is approximately 13-fold higher for persons with schizophrenia compared to the general population.
“a recent meta-analysis estimated that the risk of suicide was approximately 13-fold higher for persons with schizophrenia as compared to the general population (Saha et al. 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Saha et al. 2007 source
It may state two separate claims as one.
InterpretationreasoningAll studies find a significant and very low life expectancy in persons with schizophrenia.
“In conclusion, all studies find a significant and very low life expectancy in persons with schizophrenia.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationPersons with schizophrenia are more vulnerable to chronic physical diseases; risk of medical disease is higher and prognosis is poorer.
“Recently, it has been suggested that persons with schizophrenia are more vulnerable to chronic physical diseases; the risk of medical disease is higher, and the prognosis is poorer (Laursen et al. 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2012 source
Probably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
InterpretationreasoningLowering of somatic disorders must be a combined effort of all somatic specialties.
“This is obviously just a mathematical thought experiment, but it nevertheless illustrates that the lowering of somatic disorders must be a combined effort of all somatic specialties.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationIn a Danish study substituting rate of mortality from different causes in schizophrenia with rate from general population, results are not clear-cut because high mortality rates from cancer and heart disease 'eat' away expected beneficiary impact of lowering a specific mortality rate.
“The results are not as clear-cut as expected because high mortality rates (from, e.g., cancer and heart disease)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationThe Charlson index is twofold higher among persons with schizophrenia compared to the general population, suggesting increased occurrence of somatic disorders.
“Furthermore, the paper showed that the Charlson index is twofold higher among persons with schizophrenia compared to the general population, which suggests there is an increased occurrence of somatic disorders in these individuals.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. It may state two separate claims as one.
InterpretationreasoningAlthough prevalence of some somatic disorders seems same or lower among schizophrenic patients, risk from early death caused by other somatic disorders or suicide and accidents should be kept in mind.
“Although the prevalence of some somatic disorders (and causes of death) seems to be the same or even lower among schizophrenic patients, the risk from early death caused by other somatic disorders or suicide and accidents should be kept in mind.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationPhysical illnesses in persons with schizophrenia are common but are diagnosed late and treated insufficiently.
“Physical illnesses in persons with schizophrenia are common but are diagnosed late and treated insufficiently.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2012 source
It may state two separate claims as one.
PremisecitationAntipsychotics, particularly atypical antipsychotics, have been associated with weight gain, dyslipidemia, diabetes, and other cardiac risk factors.
“Antipsychotics, in particular atypical antipsychotics, have been associated with weight gain, dyslipidemia, diabetes, and other cardiac risk factors (Newcomer 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Newcomer 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
InterpretationcitationThe association between schizophrenia and reduced rheumatoid arthritis could be explained by reduced tendency of patients with schizophrenia to report musculoskeletal pain.
“The authors concluded that the association could be explained by the reduced tendency of patients with schizophrenia to report musculoskeletal pain (Mors et al. 1999).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mors et al. 1999 source
It may state two separate claims as one.
InterpretationcitationAlthough there is increased somatic comorbidity among persons with schizophrenia, mortality from natural causes is extremely high, suggesting excess mortality may be partly rooted in higher rates of somatic disorders and partly in underdetection or undertreatment of chronic disorders.
“Although there is increased somatic comorbidity among persons with schizophrenia, the study also showed that mortality from natural causes is extremely high in patients with schizophrenia, and this suggests that the excess mortality may be partly rooted in higher rates of somatic disorders and partly in underdetection or undertreatment of chronic disorders (Laursen et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationThe risk of suicide and accidents among patients with schizophrenia is high.
“The risk of suicide and accidents among patients with schizophrenia is high.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2012 source
It may state two separate claims as one.
InterpretationcitationDifferent causes of mortality do not contribute equally or work independently.
“In the same way, the different causes of mortality do not contribute equally or work independently.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationA Danish study found rates of invasive procedures were considerably lower and survival after first contact to hospital for heart disease was reduced in persons with schizophrenia compared to the general population.
“A Danish study has found that the rates of invasive procedures were considerably lower and the survival after first contact to a hospital for heart disease was reduced in persons with schizophrenia compared to the general population (Laursen et al. 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2009 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Interpretationnone givenHigh mortality rates caused by other sources would lower the risk of getting a disease (or dying from it), especially if the disease has late onset.
“High mortality rates caused by other sources would lower the risk of getting a disease (or dying from it), especially if the disease has a late onset, as is common with some cancers, for example.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationPersons with schizophrenia tend to have an unhealthy lifestyle (poor diet, smoking, excess alcohol consumption, and lack of exercise).
“Persons with schizophrenia tend to have an unhealthy lifestyle (poor diet, smoking, excess alcohol consumption, and lack of exercise).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laursen et al. 2012 source
It may state two separate claims as one.
PremisecitationPatients with a psychiatric disorder tend to use medical services to a lesser degree, which could lead to increased mortality.
“Furthermore, patients with a psychiatric disorder tend to use medical services to a lesser degree, which could lead to an increased mortality (Cradock-O' Leary et al. 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cradock-O' Leary et al. 2002 source
It may state two separate claims as one.
PremisecitationRaedler 2010 concluded antipsychotics increased risk of metabolic syndrome, sudden cardiac death, and myocarditis/cardiomyopathy.
“Raedler (2010) reviewed the effect of antipsychotic drugs and concluded that antipsychotics increased the risk of metabolic syndrome, sudden cardiac death, and myocarditis/cardiomyopathy.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Raedler 2010 source
It may state two separate claims as one.
PremisecitationA Helsinki study found 0.37-fold use of antihypertensive drugs and 0.47-fold use of lipid-lowering drugs compared to the general population in schizophrenia.
“A study from Helsinki (Lahti et al. 2012) found a 0.37-fold use of antihypertensive drugs and a 0.47-fold use of lipid-lowering drugs compared to the general population.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lahti et al. 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
InterpretationreasoningAntipsychotic medication may cause adverse effects, which may negatively affect mortality, but it is unclear how different antipsychotic drugs may affect excess mortality.
“Antipsychotic medication may cause adverse effects, which may negatively affect mortality, but it is unclear how different antipsychotic drugs may affect the excess mortality.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationTreatment with varenicline also increased the chance of smoking cessation, although the evidence is weaker than for bupropion.
“Treatment with varenicline also increased the chance of smoking cessation, although the evidence is weaker than for bupropion (Williams et al. 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Williams et al. 2012 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationIn the general population in Denmark, smoking-related illnesses account for a reduction in life expectancy of 3.5 years for men and 3.0 years for women.
“In the general population in Denmark, smoking-related illnesses account for a reduction in life expectancy of 3.5 years for men and 3.0 years for women ( Juel & Sørensen 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Juel & Sørensen 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
InterpretationcitationA number of studies indicate that smoking is far more frequent among people with schizophrenia and contributes substantially to the reduced life expectancy in this patient group.
“Even though we lack national statistics on smoking habits for people with schizophrenia, a number of studies indicate that smoking is far more frequent among people with schizophrenia and contributes substantially to the reduced life expectancy in this patient group.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationSeveral investigators later concluded that Miles's estimates were most likely too high.
“Several investigators later concluded that Miles's estimates were most likely too high for various reasons (Blair-West et al. 1997, 1999;Bostwick & Pankratz 2000;Inskip et al. 1998;Palmer et al. 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationWeight gains resulting in a BMI of 30 or more occurred among 2.73% of these patients per year during the first three years of treatment.
“Weight gains resulting in a BMI of 30 or more occurred among 2.73% of these patients per year during the first three years of treatment ( Jerrell et al. 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jerrell et al. 2010 source
It may state two separate claims as one.
PremisecitationA large randomized clinical trial of first-episode patients treated with different antipsychotic drugs found that all antipsychotic drugs were associated with a greater than 7% increase in weight during the trial; proportion of patients affected ranged from 37% (ziprasidone) to 86% (olanzapine).
“A large randomized clinical trial of first-episode patients treated with different antipsychotic drugs (Kahn et al. 2008) found that all antipsychotic drugs were associated with a greater than 7% increase in weight during the trial; proportion of patients affected ranged from 37% (ziprasidone) to 86% (olanzapine).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kahn et al. 2008 source
It may state two separate claims as one.
InterpretationreasoningThe lifestyle interventions are not only effective but are also achievable for the participants.
“This indicates that the lifestyle interventions are not only effective but are also achievable for the participants.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisenone givenIn addition to the effect on weight, significant changes have been linked with other clinically relevant somatic risk factors, including the levels of body fat percentage, fasting plasma glucose, and blood fat as well as waist measurement.
“In addition to the effect on weight, significant changes have been linked with other clinically relevant somatic risk factors, including the levels of body fat percentage, fasting plasma glucose, and blood fat as well as waist measurement.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
InterpretationcitationThe excess risk of cardiovascular disease in CATIE patients was partly explained by higher frequency of cigarette smoking, although relative contributions of specific antipsychotic agents, diet, exercise, and quality of medical care remain to be clarified.
“The excess risk was concluded to be partly explained by a higher frequency of cigarette smoking, although the relative contributions to cardiac risk of specific antipsychotic agents, diet, exercise, and quality of medical care remain to be clarified.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Goff et al. 2005 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationMiles (1977) estimated that 15% of persons with unipolar affective disorder, 15% with alcoholism, and 10% with schizophrenia would die from suicide.
“One of the most cited papers is the review written by Miles (1977), which estimated that 15% of persons with unipolar affective disorder, 15% with alcoholism, and 10% with schizophrenia would die from suicide.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Miles 1977 source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe authors of the largest Dutch study concluded that the training could prevent VO2 max from declining.
“The training was twice a week for six months, and the authors concluded that the training could prevent VO 2 max from declining.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scheewe et al. 2012 source
It may state two separate claims as one.
InterpretationreasoningCurrent evidence suggests that bupropion, varenicline, nicotine substitution, and smoking cessation programs are effective.
“More studies on the efficacy of different smoking cessation methods are needed, but current evidence suggests that bupropion, varenicline, nicotine substitution, and smoking cessation programs are effective.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationSome evidence suggests that both bupropion and varenicline can increase the chances of quitting smoking among people with schizophrenia.
“Several studies have investigated factors affecting the success of smoking cessation among people with schizophrenia, and some evidence suggests that both bupropion and varenicline can increase the chances of quitting smoking.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationSeveral studies have indicated that dietary habits are partly responsible for weight gain in schizophrenia, but medication can also independently cause weight gain.
“Several studies have indicated that dietary habits are partly responsible for weight gain in schizophrenia, but medication can also independently cause weight gain.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Study design and conductnone givenMiles's review was based on rather small studies with selected samples and brief follow-up periods.
“However, this review was based on rather small studies with selected samples and brief follow-up periods.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Miles 1977 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
InterpretationreasoningThere is a lack of studies on long-term outcomes in persons using antipsychotic drugs, which impedes establishment of clear guidelines in use of drugs.
“We have included only a few of the most recent papers to illustrate the lack of studies on long-term outcomes in persons using antipsychotic drugs, which impedes the establishment of clear guidelines in the use of the drugs.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
InterpretationreasoningThese estimates are lower than reported in the most cited papers in the field, but the figures are still substantial.
“These estimates are lower than reported in the most cited papers in the field, but the figures are still substantial and emphasize the continuous need for prevention of suicide among people with schizophrenia.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationPalmer and colleagues (2005) estimated the lifetime risk to be 5.6% for schizophrenia.
“Inskip et al. (1998) estimated the lifetime risk to be 6% for affective disorder, 7% for alcohol dependence, and 4% for schizophrenia, whereas Palmer and colleagues (2005) estimated the lifetime risk to be 5.6% for schizophrenia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Palmer et al. 2005 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Premisenone givenNo solid epidemiological studies to date have tested to which extent any or all of the above-mentioned factors can explain the excess mortality in schizophrenia.
“However, it is worth noting that no solid epidemiological studies to date have tested to which extent any or all of the above-mentioned factors can explain the excess mortality in schizophrenia.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
InterpretationreasoningThe major sources of excess mortality have changed over the past 70 years.
“However, the major sources of excess mortality have changed over the past 70 years.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
InterpretationreasoningThe lifestyle of people with mental illness can be changed, and to a great extent these individuals also want this change.
“The lifestyle of people with mental illness can be changed, and to a great extent these individuals also want this change.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
Premisenone givenSchizophrenia has a very strong impact on income, educational attainment, marital status, and other indicators associated with health and mortality.
“Furthermore, schizophrenia has a very strong impact on income, educational attainment, marital status, and other indicators associated with health and mortality.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Premisenone givenLifestyle factors such as excess alcohol consumption and tobacco use and little attention to a healthy diet are more prevalent in psychiatric patients.
“Second, lifestyle factors such as excess alcohol consumption and tobacco use and little attention to a healthy diet are more prevalent in psychiatric patients.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
InterpretationreasoningPeople suffering from mental illness encounter a number of barriers to lifestyle changes, including illness symptoms, adverse drug effects, and life situations.
“People suffering from mental illness encounter a number of barriers to lifestyle changes, including illness symptoms, adverse drug effects, and life situations.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisenone givenThe effect of nicotine substitution on persons with depression is the same as that on smokers without depression, corresponding to a cessation success rate of 14% to 22% after a six-month smoking cessation intervention.
“The effect of nicotine substitution on persons with depression is the same as that on smokers without depression, corresponding to a cessation success rate of 14% to 22% after a six-month smoking cessation intervention.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
Premisenone givenIt has proven difficult to recruit people with bipolar disorders and ongoing depression for smoking cessation interventions, and only a very limited number of studies focus on long-term maintenance of achieved smoking cessation.
“In general, it has proven difficult to recruit people with bipolar disorders and ongoing depression for smoking cessation interventions, and only a very limited number of studies focus on long-term maintenance of achieved smoking cessation.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premisenone givenWeak evidence also indicates that payment for participation in a smoking cessation program has a positive effect, but it is uncertain whether this also applies to the long term.
“Weak evidence also indicates that payment for participation in a smoking cessation program has a positive effect, but it is uncertain whether this also applies to the long term.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premisenone givenThe literature indicates that people with schizophrenia tolerate varenicline, which can increase the chance of smoking cessation, at least in the short term.
“The effect of varenicline is not as clear, but the literature indicates that people with schizophrenia tolerate it, which can increase the chance of smoking cessation, at least in the short term.”
Quote in the paperNot a substantial claimProbably not a substantial claim. It may state two separate claims as one.
Interpretationnone givenMounting evidence suggests that people suffering from schizophrenia have increased morbidity and mortality.
“Mounting evidence suggests that people suffering from schizophrenia have increased morbidity and mortality.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
InterpretationreasoningExcess death following hospitalization for a mental disorder indicates that a current mental disorder is a risk factor contributing to death from a physical disorder, and that the health system fails to prevent, identify, and treat physical diseases during hospitalization for a mental disorder.
“Excess death following hospitalization for a mental disorder indicates not only that a current mental disorder is a risk factor contributing to death from a physical disorder, but also that the health system fails to prevent, identify, and treat physical diseases during hospitalization for a mental disorder.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Premisenone givenEvidence of the effect of bupropion and other antidepressant drugs to promote smoking cessation is not as clear but findings indicate a slightly higher tendency of smoking cessation among people with depression who took these drugs.
“Evidence of the effect of bupropion and other antidepressant drugs to promote smoking cessation is not as clear but findings indicate a slightly higher tendency of smoking cessation among people with depression who took these drugs.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper may give no reason why it holds.
Interpretationnone givenA significant share of this excess mortality, which shortens life by 15 to 20 years, is caused by somatic illness linked with an unhealthy lifestyle.
“We also know that a significant share of this excess mortality, which shortens life by 15 to 20 years, is caused by somatic illness linked with an unhealthy lifestyle.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
Interpretationnone givenDifficulties in diagnosing somatic comorbidities, undertreatment of diagnosed disorders, or even untoward effects of the treatment of schizophrenia (e.g., diabetes, obesity) are likely to contribute to excess mortality.
“First, difficulties in diagnosing somatic comorbidities, undertreatment of diagnosed disorders, or even untoward effects of the treatment of schizophrenia (e.g., diabetes, obesity) are likely to contribute and could suggest possible avenues for prevention.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
Premisenone givenAlthough excess mortality, and to some extent excess physical morbidity, has been amply documented, only a few studies have documented the causes of this excess mortality.
“Although excess mortality, and to some extent excess physical morbidity, has been amply documented, only a few studies have documented the causes of this excess mortality.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Premisenone givenModerate evidence indicates that nicotine substitution treatment increases cessation of smoking among people with previous or ongoing depression.
“Moderate evidence indicates that nicotine substitution treatment increases cessation of smoking among people with previous or ongoing depression.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premisenone givenIn the case of people with schizophrenia, moderate evidence suggests that bupropion can nearly triple the chance of smoking cessation after six months, with no negative effects on psychotic symptoms.
“In the case of people with schizophrenia, moderate evidence suggests that bupropion can nearly triple the chance of smoking cessation after six months, with no negative effects on psychotic symptoms.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationInskip et al. (1998) estimated the lifetime risk to be 6% for affective disorder, 7% for alcohol dependence, and 4% for schizophrenia.
“Inskip et al. (1998) estimated the lifetime risk to be 6% for affective disorder, 7% for alcohol dependence, and 4% for schizophrenia, whereas Palmer and colleagues (2005) estimated the lifetime risk to be 5.6% for schizophrenia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Inskip et al. 1998 source
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Premisenone givenA number of studies indicate that health care employees with negative attitudes may actually form a barrier for lifestyle changes among people with mental illness.
“A number of studies indicate that health care employees with negative attitudes may actually form a barrier for lifestyle changes among people with mental illness.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
InterpretationreasoningThis indicates that study participants are able to carry out the lifestyle interventions and that the interventions are effective.
“This indicates that study participants are able to carry out the lifestyle interventions and that the interventions are effective.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Premisenone givenOutcomes are not known for nonmotivated psychiatric patients in lifestyle interventions that focus on diet.
“Outcomes are not known for nonmotivated psychiatric patients in lifestyle interventions that focus on diet.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
InterpretationreasoningThe lifestyles of the mentally ill are generally influenced by a number of dilemmas and conflicting feelings, and this implies that good intentions for a healthier lifestyle may not always result in taking action.
“The lifestyles of the mentally ill are generally influenced by a number of dilemmas and conflicting feelings, and this implies that good intentions for a healthier lifestyle may not always result in taking action.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Premisenone givenThe concept of schizophrenia was originally defined to include patients with especially poor outcomes.
“The concept of schizophrenia was originally defined to include patients with especially poor outcomes.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
InterpretationreasoningThe mortality gap not only persists but may actually even be increasing.
“Thus, the mortality gap not only persists but may actually even be increasing.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationnone givenThis group of patients still has an exceptionally short life expectancy because of very high mortality in all age groups.
“This group of patients still has an exceptionally short life expectancy because of very high mortality in all age groups.”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
No mortality occurs in the age group 0-15 years old.
“Note that we have assumed no mortality in the age group 0-15 years old.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cardiometabolic risk factors such as cardiovascular disease and obesity are recognised major contributors to increased mortality in schizophrenia.
“While causes are multifactorial, cardiometabolic risk factors such as cardiovascular disease and obesity are recognised major contributors [1,2,10,11].”
From A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis. (2022) · cites this paper as [1]
The Mortality Rate Ratios section reports an elevated cardiovascular mortality rate in schizophrenia, and the Further Studies section identifies obesity as a plausible contributor to excess mortality. But that section also says few studies have documented the causes and no solid epidemiological studies have established how much these factors explain excess mortality. Calling both recognised major contributors overstates the paper's conclusion, particularly for obesity. (LLM, conf=0.87)
Experimental — accuracy not yet measuredLife expectancy in patients with schizophrenia is reduced by 20 years for men and 15 years for women compared to the general population.
“Life expectancy in patients with schizophrenia is reduced by 20 years for men and 15 years for women compared to the general population.”
People with schizophrenia and other psychotic disorders die earlier than their peers in the general population, by around 15-20 years according to recent estimates.
“People with schizophrenia and other psychotic disorders die earlier than their peers in the general population, with recent estimates suggesting by around 15–20 years.1–10”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [6]
Consistent evidence has accrued that people with psychotic disorder have higher mortality rates than the general population.
“Over the past decades, consistent evidence has accrued that people with psychotic disorder have higher mortality rates than the general population.1–9”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
A study is described as randomized but cited as observational
MinorThe text calls the 18,154-patient comparison a randomized trial, while the cited reference identifies it as an observational study.
“A randomized trial including 18,154 patients with schizophrenia compared the effects of ziprasidone and olanzapine (Strom et al. 2011).”
“Strom BL, Eng SM, Faich G, Reynolds RF, D'Agostino RB, et al. 2011. Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).”
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Motivational interviewing: preparing people for change.
Miller, W. R., & Rollnick, S. (2002) · Cited by 7,002
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589
New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality
Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., & Ghali, W. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.03.012 · Cited by 2,439
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
A Systematic Review of the Prevalence of Schizophrenia
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
The Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
Self-citationThe Danish Psychiatric Central Research Register
Mors, O., Perto, G. P., & Mortensen, P. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810395825 · Cited by 1,589
Self-citation(1992) · PubMed · Cited by 1,429
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression
Goodwin, F. K., & Jamison, K. R. (2007) · Medical Entomology and Zoology · Cited by 1,325
Salomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A., Begum, N., Shah, R., Karyana, M., Kosen, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61680-8 · Cited by 1,322
Excess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
The Lifetime Risk of Suicide in Schizophrenia: A Reexamination
Palmer, B. A., Pankratz, V. S., & Bostwick, J. M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.247 · Cited by 1,026
Affective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778
Self-citationThe 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements
Dixon, L. B., Dickerson, F., Bellack, A. S., Bennett, M., Dickinson, D., Goldberg, R. W., Lehman, A., Tenhula, W. N., Calmes, C., Pasillas, R. M., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp115 · Cited by 774
Suicide and Primary Affective Disorders
Guzé, S. B., & Robins, E. (1970) · The British Journal of Psychiatry · doi:10.1192/bjp.117.539.437 · Cited by 724
Chang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019590 · Cited by 714
Absolute Risk of Suicide After First Hospital Contact in Mental Disorder
Nordentoft, M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.113 · Cited by 689
Self-citationMortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679
Suicide Risk in Relation to Psychiatric Hospitalization: Evidence Based on Longitudinal Registers
Qin, P., & Nordentoft, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.427 · Cited by 620
Self-citationComorbidities and mortality in persons with schizophrenia: a Swedish national cohort study
Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050599 · Cited by 619
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia
Inskip, H., Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.1.35 · Cited by 579
Birthweight and mortality in adulthood: a systematic review and meta-analysis
Risnes, K. R., Vatten, L. J., Baker, J. L., Jameson, K., Sovio, U., Kajantie, E., Osler, M., Morley, R., Jokela, M., Painter, R. C., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq267 · Cited by 576
Motivational Interviewing: Preparing People for Change
Dabbo, S., & Dabbo, N. (2010) · University of Toronto Medical Journal · doi:10.5015/utmj.v87i2.1178 · Cited by 533
Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes
Kirkbride, J. B., Fearon, P., Morgan, C., Dazzan, P., Morgan, K. D., Tarrant, J., Lloyd, T., Holloway, J. D., Hutchinson, G. A., Leff, J., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.250 · Cited by 532
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C.-Y., Agerbo, E., & Mortensen, P. B. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.521 · Cited by 527
Self-citationA Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness
Daumit, G. L., Dickerson, F. B., Wang, N.-Y., Dalcin, A., Jerome, G. J., Anderson, C. A. M., Young, D. R., Frick, K. D., Yu, A., Gennusa, J. V., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214530 · Cited by 523
Life expectancy and cardiovascular mortality in persons with schizophrenia
Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835035ca · Cited by 518
Self-citationMurray, R. M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.002 · Cited by 516
Schizophrenics Kill Themselves Too: A Review of Risk Factors for Suicide
Caldwell, C. B., & Gottesman, I. I. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.4.571 · Cited by 511
Life expectancy among persons with schizophrenia or bipolar affective disorder
Laursen, T. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.008 · Cited by 508
Self-citationCONDITIONS PREDISPOSING TO SUICIDE: A REVIEW
MILES, C. P. (1977) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197704000-00002 · Cited by 504
Quality of Medical Care and Excess Mortality in Older Patients With Mental Disorders
Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. J., & Krumholz, H. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.565 · Cited by 490
Severe Mental Illness and Risk of Cardiovascular Disease
Newcomer, J. W., & Hennekens, C. H. (2007) · JAMA · doi:10.1001/jama.298.15.1794 · Cited by 433
Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer, J. W. (2007) · PubMed · Cited by 416
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
Self-citationRuneson, B., Tidemalm, D., Dahlin, M., Lichtenstein, P., & Langstrom, N. (2010) · BMJ · doi:10.1136/bmj.c3222 · Cited by 396
Laursen, T. M., Munk-Olsen, T., Nordentoft, M., & Mortensen, P. B. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0612 · Cited by 380
Self-citationQuality of Preventive Medical Care for Patients With Mental Disorders
Druss, B. G., Rosenheck, R. A., Desai, M. M., & Perlin, J. B. (2002) · Medical Care · doi:10.1097/00005650-200202000-00007 · Cited by 376
Psychiatric illness and risk factors for suicide in Denmark
Mortensen, P. B., Agerbo, E., Erikson, T., Qin, P., & Westergaard‐Nielsen, N. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06376-x · Cited by 348
Self-citationMedical comorbidity in women and men with schizophrenia: A population-based controlled study
Carney, C. P., Jones, L., & Woolson, R. F. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00563.x · Cited by 343
Disparities in Diabetes Care: Impact of Mental Illness
Frayne, S. M., Halanych, J. H., Miller, D. R., Wang, F., Lin, H., Pogach, L., Sharkansky, E. J., Keane, T. M., Skinner, K. M., Rosen, C. S., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2631 · Cited by 336
Is schizophrenia a syndrome of accelerated aging?
Kirkpatrick, B., Messias, E., Harvey, P. D., Fernandez-Egea, E., & Bowie, C. R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm140 · Cited by 335
Mental disorders and cause-specific mortality
Joukamaa, M., HeliöVaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.6.498 · Cited by 328
Laursen, T. M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Nordentoft, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067133 · Cited by 313
Self-citationEpidemiology of Schizophrenia: Review of Findings and Myths
Messias, E., Chen, C., & Eaton, W. W. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.007 · Cited by 307
Interventions for smoking cessation and reduction in individuals with schizophrenia
Tsoi, D. T., Porwal, M., & Webster, A. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007253.pub3 · Cited by 304
Schneck, J. M. (1960) · Medical Entomology and Zoology · Cited by 304
Laursen, T. M., Munk-Olsen, T., Agerbo, E., Gasse, C., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.61 · Cited by 271
Self-citationDeath rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998
Lawrence, D. M., D'Arcy, C., Holman, J., Jablensky, A. V., & Hobbs, M. S. T. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.1.31 · Cited by 269
EFFECTS OF EXERCISE ON MENTAL AND PHYSICAL HEALTH PARAMETERS OF PERSONS WITH SCHIZOPHRENIA
Beebe, L. H., Tian, L., Morris, N., Goodwin, A., Allen, S. S., & Kuldau, J. (2005) · Issues in Mental Health Nursing · doi:10.1080/01612840590959551 · Cited by 259
The epidemiology of excess mortality in people with mental illness
Lawrence, D., Kisely, S., & Pais, J. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005501202 · Cited by 258
Baker, A., Richmond, R., Haile, M., Lewin, T. J., Carr, V. J., Taylor, R. L., Jansons, S., & Wilhelm, K. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1934 · Cited by 255
Health Inequality - determinants and policies
Diderichsen, F., Andersen, I., Manuel, C., The Working Group of the Danish Review on Social Determinants of Health, Andersen, A.-M. N., Bach, E., Baadsgaard, M., Brønnum-Hansen, H., Hansen, F. K., Jeune, B., et al. (2012) · Scandinavian Journal of Public Health · doi:10.1177/1403494812457734 · Cited by 247
Laursen, T. M., Munk‐Olsen, T., & Gasse, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024597 · Cited by 239
Self-citationLifetime suicide risk in major depression: sex and age determinants
Blair-West, G. W., Cantor, C. H., Mellsop, G. W., & Eyeson‐Annan, M. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00004-x · Cited by 233
Medical Comorbidity in Women and Men With Bipolar Disorders: A Population-Based Controlled Study
Carney, C. P., & Jones, L. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000237316.09601.88 · Cited by 229
Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., Rosenheck, R., Davis, S. M., Hsiao, J. K., Stroup, T. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.006 · Cited by 223
Osborn, D. P., Wright, C. A., Levy, G., King, M. B., Deo, R., & Nazareth, I. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-84 · Cited by 208
International Classification of Diseases
Musen, M. A. (2013) · Springer eBooks · doi:10.1007/978-1-4419-9863-7_1513 · Cited by 204
Use of General Medical Services by VA Patients With Psychiatric Disorders
Cradock-O'Leary, J., Young, A. S., Yano, E. M., Wang, M., & Lee, M. L. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.7.874 · Cited by 197
Migration as a risk factor for schizophrenia: A Danish population-based cohort study
Cantor-Graae, E., Pedersen, C. B., Mcneil, T. F., & Mortensen, P. B. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.2.117 · Cited by 195
Self-citationReassessing the long-term risk of suicide after a first episode of psychosis
Dutta, R., Murray, R. M., Hotopf, M., Allardyce, J., Jones, P. B., & Boydell, J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.157 · Cited by 190
Birkenaes, A. B., Opjordsmoen, S., Brunborg, C., Engh, J. A., Jonsdottir, H., Ringen, P. A., Simonsen, C., Vaskinn, A., Birkeland, K. I., Friis, S., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0614 · Cited by 185
Inequitable access for mentally ill patients to some medically necessary procedures
Kisely, S., Smith, M., Lawrence, D., Cox, M., Campbell, L. A., & Maaten, S. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060482 · Cited by 185
Caemmerer, J., Correll, C. U., & Maayan, L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.017 · Cited by 182
Bobes, J., Arango, C., Garcia-Garcia, M., & Rejas, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1030 · Cited by 181
Compton, M. T., Daumit, G. L., & Druss, B. G. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220600889256 · Cited by 177
Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates
Lawrence, D., D'Arcy, C., Holman, J., Jablensky, A. V., Threfall, T. J., & Fuller, S. A. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101005382.x · Cited by 174
Schizophrenia and rheumatoid arthritis: a review
Eaton, W. W., Hayward, C., & Ram, R. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90001-l · Cited by 172
The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study
Schmidt, L. M., Hesse, M., & Lykke, J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.011 · Cited by 171
Nielsen, R. E., Uggerby, A. S., Jensen, S. O. W., & McGrath, J. J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.025 · Cited by 162
Williams, J. M., Anthenelli, R. M., Morris, C. D., Treadow, J., Thompson, J. R., Yunis, C., & George, T. P. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07522 · Cited by 162
Bonfioli, E., Berti, L., Goss, C., Muraro, F., & Burti, L. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-78 · Cited by 154
Scheewe, T. W., van Haren, N. E. M., Sarkisyan, G., Schnack, H. G., Brouwer, R. M., de Glint, M., Hulshoff Pol, H. E., Backx, F. J. G., Kahn, R. S., & Cahn, W. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.08.008 · Cited by 148
Systematic review and collaborative recalculation of 133 693 incident cases of schizophrenia
van der Werf, M., Hanssen, M., Köhler, S., Verkaaik, M., Verhey, F. R., RISE Investigators, van Winkel, R., van Os, J., & Allardyce, J. (2014) · Psychological Medicine · doi:10.1017/s0033291712002796 · Cited by 148
Mortality and causes of death in schizophrenic patients in Denmark
Mortensen, P. B., & Juel, K. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05466.x · Cited by 138
Self-citationLaursen, T. M., Labouriau, R., Licht, R. W., Bertelsen, A., Munk-Olsen, T., & Mortensen, P. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.841 · Cited by 138
Self-citationNordentoft, M., Laursen, T. M., Agerbo, E., Qin, P., Høyer, E. H., & Mortensen, P. B. (2004) · BMJ · doi:10.1136/bmj.38133.622488.63 · Cited by 136
Self-citationYoung males have a higher risk of developing schizophrenia: a Danish register study
THORUP, A., WALTOFT, B. L., PEDERSEN, C. B., MORTENSEN, P. B., & NORDENTOFT, M. (2007) · Psychological Medicine · doi:10.1017/s0033291707009944 · Cited by 131
Self-citationAt Issue: Schizophrenia and Rheumatoid Arthritis: The Negative Association Revisited
Oken, R. J., & Schulzer, M. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033407 · Cited by 129
Bipolar disorder and schizophrenia: distinct illnesses or a continuum?
Möller, H. (2003) · PubMed · Cited by 128
Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia
Angst, J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00328-6 · Cited by 127
Strom, B. L., Eng, S. M., Faich, G., Reynolds, R. F., D'Agostino, R. B., Ruskin, J., & Kane, J. M. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.08040484 · Cited by 122
Kisely, S., Campbell, L. A., & Wang, Y. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067082 · Cited by 116
Khan, A., Faucett, J., Morrison, S., & Brown, W. A. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.149 · Cited by 109
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
Lahti‐Pulkkinen, M., Tiihonen, J., Wildgust, H. J., Beary, M., Hodgson, R. E., Kajantie, E., Osmond, C., Räikkönen, K., & Eriksson, J. G. (2012) · Psychological Medicine · doi:10.1017/s0033291712000396 · Cited by 108
Down‐rating lifetime suicide risk in major depression
Blair‐West, G. W., Mellsop, G. W., & Eyeson‐Annan, M. L. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09629.x · Cited by 108
Mitchell, A. J., & Lord, O. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382056 · Cited by 108
Hippisley‐Cox, J., Parker, C., Coupland, C. A. C., & Vinogradova, Y. (2007) · Heart · doi:10.1136/hrt.2006.110171 · Cited by 106
The Role of a Fitness Intervention on People with Serious Psychiatric Disabilities.
Skrinar, G. S., Huxley, N. A., Hutchinson, D. S., Menninger, E., & Glew, P. (2005) · Psychiatric Rehabilitation Journal · doi:10.2975/29.2005.122.127 · Cited by 101
Laursen, T. M., & Nordentoft, M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.027 · Cited by 93
Self-citationMental disorders and suicide prevention
Lönnqvist, J. K., HENRIKSSON, M. M., Isometsä, E. T., MARTTUNEN, M. J., Heikkinen, M. E., Aro, H. M., & Kuoppasalmi, K. I. (1995) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1995.tb01912.x · Cited by 91
Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine
Kelly, D. L., McMahon, R. P., Liu, F., Love, R. C., Wehring, H. J., Shim, J.-C., Warren, K. R., & Conley, R. R. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04718yel · Cited by 90
Cardiovascular aspects of antipsychotics
Raedler, T. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833f46c9 · Cited by 89
A population-based register study of the association between schizophrenia and rheumatoid arthritis
Mors, O., Mortensen, P. B., & Ewald, H. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00030-4 · Cited by 87
Self-citationEffects of Exercise Therapy on Cardiorespiratory Fitness in Patients with Schizophrenia
SCHEEWE, T. W., TAKKEN, T., KAHN, R. S., CAHN, W., & BACKX, F. J. G. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318258e120 · Cited by 79
Pedersen, C. B., & Mortensen, P. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj169 · Cited by 79
Self-citationLaursen, T. M., Mortensen, P. B., MacCabe, J. H., Cohen, D., & Gasse, C. (2013) · Psychological Medicine · doi:10.1017/s003329171300216x · Cited by 78
Self-citationPetersen, L. A., Normand, S. T., Druss, B. G., & Rosenheck, R. A. (2003) · Health Services Research · doi:10.1111/1475-6773.00104 · Cited by 73
MORTALITY IN NORWEGIAN MENTAL HOSPITALS 1926–1941
Ødegård, Ø. (1951) · Human Heredity · doi:10.1159/000150667 · Cited by 73
Epidemiological comparison of schizophrenia and bipolar disorder
Torrey, E. F. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00107-3 · Cited by 71
Mortality in schizophrenia and related psychoses: data from two cohorts, 1875–1924 and 1994–2010
Healy, D., Le Noury, J., Harris, M., Butt, M., Linden, S., Whitaker, C., Zou, L., & Roberts, A. P. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001810 · Cited by 69
Thomas, S. H. L., Drici, M. D., Hall, G. C., Crocq, M. A., Everitt, B., Lader, M. H., Jeunne, C. L., Naber, D., Priori, S., Sturkenboom, M., et al. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01563.x · Cited by 67
Baker, A. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1934 · Cited by 64
Treatment of Cardiac Risk Factors Among Patients With Schizophrenia and Diabetes
Weiss, A. P., Henderson, D. C., Weilburg, J. B., GOFF, D. C., Meigs, J. B., Cagliero, E., & Grant, R. W. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.8.1145 · Cited by 59
MENTAL DISORDERS AND QUALITY OF CARE AMONG POSTACUTE MYOCARDIAL INFARCTION OUTPATIENTS
Desai, M. M., Rosenheck, R. A., Druss, B. G., & Perlin, J. B. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200201000-00014 · Cited by 56
Briskman, I., Bar, G., Boaz, M., & Shargorodsky, M. (2012) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.43.4.d · Cited by 54
Mortality and causes of death in older patients with schizophrenia
Talaslahti, T., Alanen, H., Hakko, H., Isohanni, M., Häkkinen, U., & Leinonen, E. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2833 · Cited by 54
Kodesh, A., Goldshtein, I., Gelkopf, M., Goren, I., Chodick, G., & Shalev, V. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0478-9 · Cited by 53
Juel, K., Sørensen, J. R., & Brønnum‐Hansen, H. (2008) · Scandinavian Journal of Public Health · doi:10.1177/1403494808097590 · Cited by 44
No mental health without physical health.
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60211-0 · Cited by 44
Fernandez-Egea, E., García-Rizo, C., Miller, B., Parellada, E., Justicia, A., Bernardo, M., & Kirkpatrick, B. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318230343f · Cited by 43
Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressingFRAXE
Abrams, M. T., Doheny, K. F., Mazzocco, M. M. M., Knight, S. J. L., Baumgardner, T. L., Freund, L. S., Davies, K. E., & Reiss, A. L. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970221)74:1 · Cited by 42
Westman, J., Gissler, M., & Wahlbeck, K. (2012) · The European Journal of Public Health · doi:10.1093/eurpub/ckr068 · Cited by 37
Jerrell, J., McIntyre, R., & Tripathi, A. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.2 · Cited by 31
Psychiatric service development and suicide
Hawton, K., & Saunders, K. E. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61871-1 · Cited by 31
Fetal Growth and Schizophrenia: A Nested Case-Control and Case-Sibling Study
Nielsen, P. R., Mortensen, P. B., Dalman, C., Henriksen, T. B., Pedersen, M. G., Pedersen, C. B., & Agerbo, E. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs148 · Cited by 31
Self-citationWhat risk factors tell us about the causes of schizophrenia and related psychoses
Kelly, J., & Murray, R. M. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0019-1 · Cited by 27
Mortality in a psychiatric population: A Nigerian psychiatric hospital experience
Abiodun, O. A. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05184.x · Cited by 26
Severe mental illness and mortality of hospitalized ACS patients in the VHA
Plomondon, M. E., Ho, P. M., Wang, L., Greiner, G. T., Shore, J. H., Sakai, J. T., Fihn, S. D., & Rumsfeld, J. S. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-146 · Cited by 26
Fernández-Egea, E., García‐Rizo, C., Miller, B. J., Justicia, A., Bernardo, M., & Kirkpatrick, B. W. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.491 · Cited by 5
Flagged first, then by citations
1 of the 132 references couldn’t be matched to a known paper.
Research works printed but not linked: 11
- Alstrøm CH, 1942, Mortality in Mental Hospitals
- Cent. Prev. Board Health, 2006, Fysisk aktivitet i psykiatrien—undervisningsmateriale. [Physical activity in psychiatry—educational material.]
- Mitchell AJ, 2010, J. Psychol. Pharmacol., 24, 69
- Moller HJ, 2003, J. Clin. Psychiatry, 64, 23
- Newcomer JW, 2007, J. Clin. Psychiatry, 68, 8
- Nordentoft M, 2012, Psykisk Sygdom og ændringer i Livsstil. [Psychiatric Disease and Lifestyle Changes.]
- Odegard O, 1951, Acta Gen. Stat. Med., 2, 141
- Pedersen CB, 2006, Dan. Med. Bull., 53, 441
- Pedersen PV, 2012, SUSY Udsat 2012. Sundhedsprofil for social udsatte i Danmark 2012 og udviklingen siden 2007. [SUSY Exposed 2012. Health profile for socially vulnerable groups in Denmark 2012 and developments since 2007.]
- Prochaska JO, 1992, Prog. Behav. Modif., 28, 183
- Tsoi DT, 2013, Cochrane Database Syst. Rev., 2, CD007253
Cited by
Sorted by citations
Walker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870
Self-citationCorrell, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729
Charlson, F. J., Ferrari, A. J., Santomauro, D. F., Diminic, S., Stockings, E., Scott, J. G., McGrath, J. J., & Whiteford, H. A. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby058 · Cited by 1,647
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer‐Lindenberg, A., Weinberger, D. R., Cannon, T. D., O’Donovan, M. C., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,163
Premature Mortality Among Adults With Schizophrenia in the United States
Olfson, M., Gerhard, T., Huang, C., Crystal, S., & Stroup, T. S. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1737 · Cited by 1,083
Keepers, G. A., Fochtmann, L. J., Anzia, J. M., Benjamin, S., Lyness, J. M., Mojtabai, R., Servis, M. E., Walaszek, A., Buckley, P. F., Lenzenweger, M. F., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.177901 · Cited by 994
Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Penninx, B. W. J. H., & Lange, S. M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/bpenninx · Cited by 566
Dalsgaard, S., Thorsteinsson, E., Trabjerg, B. B., Schullehner, J., Plana-Ripoll, O., Brikell, I., Wimberley, T., Thygesen, M., Madsen, K. B., Timmerman, A., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3523 · Cited by 510
Self-citationImpaired Glucose Homeostasis in First-Episode Schizophrenia
Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3803 · Cited by 475
“Exclusion criteria were (1) studies only assessing diagnosis of type 1 or type 2 diabetes, (2) patients with multiple episodes of schizophrenia, (3) chronic antipsychotic treatment (>2 weeks’ lifetime exposure), (4) substance- or medicationinduced psychotic disorder, (5) physical comorbidity that may affect glucose ho…”
BackgroundMethodCardiovascular disease in patients with severe mental illness
Nielsen, R. E., Banner, J., & Jensen, S. E. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00463-7 · Cited by 389
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 365
“Today, the largest single cause of death in schizophrenia is cardiovascular disease (CVD) (2, 3), similar to the general population.”
BackgroundGarcía-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306
Shefer, G., Henderson, C., Howard, L. M., Murray, J., & Thornicroft, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111682 · Cited by 299
“More specifically, these explanations include side effects of medication, failure to seek early treatment or to seek it at all, difficulties in managing medication and complying with treatment more generally, unhealthy life-style and poor economic conditions affecting access to healthcare services [2], [6], [9].”
BackgroundA Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Koblan, K. S., KENT, J. M., Hopkins, S. C., Krystal, J. H., Cheng, H., GOLDMAN, R. S., & Loebel, A. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911772 · Cited by 311
Henderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288
Cross talk: the microbiota and neurodevelopmental disorders
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00490 · Cited by 271
“This disorder can have a major detrimental impact on functioning, and is associated with a reduced life expectancy (Laursen et al., 2014; Schoenbaum et al., 2017; Strati et al., 2017) and a suicide rate of 5% (Hor and Taylor, 2010). schizophrenia is classically characterized by positive (delusions,…”
BackgroundAntipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia
Taipale, H., Mittendorfer-Rutz, E., Alexanderson, K., Majak, M., Mehtälä, J., Hoti, F., Jedenius, E., Enkusson, D., Leval, A., Sermon, J., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.12.010 · Cited by 262
“Patients with schizophrenia have a 15–20 year shorter life expectancy than the general population (Laursen et al., 2014), and side effects of antipsychotic medications are considered a putative cause for the excess mortality (Glassman and Bigger Jr.”
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., Di Forti, M., & Taylor, D. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.182683 · Cited by 244
Self-citationPillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230
Genome‐wide association study of schizophrenia in Ashkenazi Jews
Goes, F. S., McGrath, J., Avramopoulos, D., Wolyniec, P., Pirooznia, M., Ruczinski, I., Nestadt, G., Kenny, E. E., Vacic, V., Peters, I., et al. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32349 · Cited by 226
“RESEARCH ARTICLE Neuropsychiatric Genetics”
Yang, Q., Li, B., Tang, J., Cui, X., Wang, Y., Li, X., Hu, J., Chen, Y., Xue, W., Lou, Y., et al. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz049 · Cited by 217
“reduced by about 20 years on average compared with the general population [3].”
BackgroundThe polygenic architecture of schizophrenia — rethinking pathogenesis and nosology
Smeland, O. B., Frei, O., Dale, A. M., & Andreassen, O. A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0364-0 · Cited by 211
A Computerized Method for Automatic Detection of Schizophrenia Using EEG Signals
Siuly, S., Khare, S. K., Bajaj, V., Wang, H., & Zhang, Y. (2020) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2020.3022715 · Cited by 212
“The expected death of the SZ patients are 2-3 times higher than normal healthy people because of preventable physical diseases, such as cardiovascular disease, metabolic disease and infections [4].”
BackgroundLong-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders
Fett, A.-K. J., Velthorst, E., Reichenberg, A., Ruggero, C. J., Callahan, J. L., Fochtmann, L. J., Carlson, G. A., Perlman, G., Bromet, E. J., & Kotov, R. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3993 · Cited by 189
Charlson, F., Baxter, A. J., Dua, T., Degenhardt, L. J., Whiteford, H., & Vos, T. (2014) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000687 · Cited by 194
Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis
Pillinger, T., Beck, K., Stubbs, B., & Howes, O. D. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.200907 · Cited by 170
Smigielski, L., Jagannath, V., Rössler, W., Walitza, S., & Grünblatt, E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0601-3 · Cited by 168
Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark
Meier, S. M., Mattheisen, M., Mors, O. N., Schendel, D., Mortensen, P. B., & Plessen, K. J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3105 · Cited by 179
Self-citationZuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157
“SCZ is thought to be one of the most severe mental disorders and the average life expectancy is ∼20 years below that of the general population (Laursen et al., 2014).”
BackgroundMortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., Heslin, M., Onyejiaka, A., Donoghue, K., Lomas, B., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu138 · Cited by 156
“Consistent with earlier research 2–6,8–10, 12, 35– 40 and the classification of”
ResultSpeyer, H., Christian Brix Nørgaard, H., Birk, M., Karlsen, M., Storch Jakobsen, A., Pedersen, K., Hjorthøj, C., Pisinger, C., Gluud, C., Mors, O., et al. (2016) · World Psychiatry · doi:10.1002/wps.20318 · Cited by 153
Self-citationMisiak, B., Stańczykiewicz, B., Łaczmański, Ł., & Frydecka, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.031 · Cited by 151
“Cardiovascularmorbidity is increasingly being recognized as amajor contributor of mortality and reduced life expectancy in patients with schizophrenia (Laursen et al., 2014).”
Das, K., & Pachori, R. B. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.102525 · Cited by 144
Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder
Hoseth, E. Z., Krull, F., Dieset, I., Mørch, R. H., Hope, S., Gardsjord, E. S., Steen, N. E., Melle, I. S., Brattbakk, H.-R., Steen, V. M., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0102-1 · Cited by 145
Social Disconnection in Schizophrenia and the General Community
Green, M. F., Horan, W. P., Lee, J., McCleery, A., Reddy, L. F., & Wynn, J. K. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx082 · Cited by 141
Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia
Wimberley, T., MacCabe, J. H., Laursen, T. M., Sørensen, H. J., Astrup, A., Horsdal, H. T., Gasse, C., & Støvring, H. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16091097 · Cited by 135
Self-citationLaursen, T. M., Plana‐Ripoll, O., Andersen, P. K., McGrath, J. J., Toender, A., Nordentoft, M., Canudas‐Romo, V., & Erlangsen, A. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.11.003 · Cited by 132
Self-citationLee, E., Liu, J., Tu, X. M., Palmer, B. W., Eyler, L. T., & Jeste, D. V. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.005 · Cited by 127
Hakulinen, C. A., McGrath, J. J., Timmerman, A., Skipper, N., Mortensen, P. B., Pedersen, C. B., & Agerbo, E. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01756-0 · Cited by 118
Self-citationAslan, Z., & Akın, M. (2021) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-021-01083-2 · Cited by 120
“Compared to normal healthy people, SZ patients have a higher mortality rate due to preventable physical illnesses [4].”
BackgroundGoldsmith, D. R., & Rapaport, M. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00046 · Cited by 115
“debilitating symptoms (5, 6), have high rates of unemployment and homelessness in the US (7, 8), and have a significantly reduced life expectancy (9).”
BackgroundTen-Year Outcomes of First-Episode Psychoses in the MRC ÆSOP-10 Study
Revier, C. J., Reininghaus, U., Dutta, R., Fearon, P., Murray, R. M., Doody, G. A., Croudace, T. J., Dazzan, P., Heslin, M., Onyejiaka, A. N., et al. (2015) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000295 · Cited by 118
“…estimates suggest that peoplewith schizophrenia, as well as other psychotic disorders, die 15 to 20 years earlier than their peers (Beary et al., 2012; Crump et al., 2013; Hoang et al., 2013; Hoang et al., 2011; Laursen et al., 2014; Nielsen et al., 2013; Saha et al., 2007; Wahlbeck et al., 2011).”
BackgroundExcess medical comorbidity and mortality across the lifespan in schizophrenia.
Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.020 · Cited by 103
Moore, S., Shiers, D., Daly, B., Mitchell, A. J., & Gaughran, F. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12431 · Cited by 107
“Schizophrenia and related disorders are associated with increased medical morbidity and mortality (1, 2).”
BackgroundMallard, T. T., Linnér, R. K., Grotzinger, A. D., Sanchez‐Roige, S., Seidlitz, J., Okbay, A., de Vlaming, R., Meddens, S. F. W., Palmer, A. A., Davis, L. K., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100140 · Cited by 99
“This runs counter to associations often observed at the phenotypic level, where individuals diagnosed with more serious mental illnesses tend to face more severe impairments and consequences in these domains.(40,41) These results raise questions about the potential ascertainment biases that affect GWASs.”
Gatov, E., Rosella, L. C., Chiu, M., & Kurdyak, P. A. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.161351 · Cited by 103
Cancer mortality in patients with schizophrenia: systematic review and meta-analysis
Zhuo, C., Tao, R., Jiang, R., Lin, X., & Shao, M. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.195776 · Cited by 93
Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting
Christiansen, S. L., HERTZ, C. L., Ferrero‐Miliani, L., Dahl, M., Weeke, P. E., LuCamp, Ottesen, G. L., Frank-Hansen, R., Bundgaard, H., & Morling, N. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.118 · Cited by 94
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Ijaz, S., Bolea-Alamanac, B. M., Davies, S., Savović, J., Richards, A., Sullivan, S. A., & Moran, P. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1848-y · Cited by 90
Liang, Z., Xu, C., Cao, Y., Kan, H., Chen, R., Yao, C., Liu, X., Xiang, Y., Wu, N., Wu, L., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.09.142 · Cited by 88
Sharma, M. D., & Acharya, U. R. (2021) · Cognitive Neurodynamics · doi:10.1007/s11571-020-09655-w · Cited by 86
Keepers, G. A., Fochtmann, L. J., Anzia, J. M., Benjamin, S., Lyness, J. M., Mojtabai, R., Servis, M. E., Walaszek, A., Buckley, P. F., Lenzenweger, M. F., et al. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.18402 · Cited by 89
“…and standardized mortality ratios that are reported to be twofold to fourfold those in the general population (Hayes et al. 2017; Heilä et al. 2005; Hjorthøj et al. 2017; Laursen et al. 2014; Lee et al. 2018; Oakley et al. 2018; Olfson et al. 2015; Tanskanen et al. 2018; Walker et al. 2015).”
BackgroundPrenatal infection and schizophrenia: A decade of further progress
Cheslack‐Postava, K., & Brown, A. S. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.05.014 · Cited by 86
Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients
An, H., Du, X., Huang, X., Qi, L., Jia, Q., Yin, G., Xiao, C., Huang, X., Ning, Y., Cassidy, R. M., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0303-7 · Cited by 80
Lifestyle Interventions and Prevention of Suicide
Berardelli, I., Corigliano, V., Hawkins, M., Comparelli, A., Erbuto, D., & Pompili, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00567 · Cited by 80
“Psychiatric patients, including patients affected by schizophrenia, bipolar disorder, schizoaffective disorder and depressive disorder, have higher mortality rates and higher suicide risk compared to the general population (1, 2).”
BackgroundSerum interleukin-6 in schizophrenia: A system review and meta-analysis
Zhou, X., Tian, B., & Han, H.-B. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155441 · Cited by 74
Liu, D., Meyer, D., Fennessy, B., Feng, C., Cheng, E., Johnson, J., Park, Y. J., Rieder, M.-K., Ascolillo, S., de Pins, A. M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01305-1 · Cited by 78
Yao, B., & Thakkar, K. N. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.016 · Cited by 82
High loading of polygenic risk in cases with chronic schizophrenia
Meier, S. M., Agerbo, E., Maier, R., Pedersen, C. B., Lang, M., Grove, J., Hollegaard, M. V., Demontis, D., Trabjerg, B. B., Hjorthøj, C. R., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.130 · Cited by 72
Self-citationAschbrenner, K., Naslund, J., Shevenell, M. D., Mueser, K., & Bartels, S. (2016) · Psychiatric quarterly · doi:10.1007/s11126-015-9395-x · Cited by 95
“Psychiatric medications are frequently cited as the cause of weight gain [2], but lifestyle behaviors are also a major contributor to obesity in this population [3].”
Harvey, P. D. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13065su1.08 · Cited by 76
“16 These findings combine to suggest that long-stay institutional treatment is not a uniformly negative influence on life expectancy.”
Rahmani, F., Ranjbar, F., Hosseinzadeh, M., Razavi, S. S., Dickens, G. L., & Vahidi, M. (2019) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2019.03.006 · Cited by 81
“3% in lifetime [4] while in Iran, specifically, lifetime prevalence is 0.”
BackgroundNi, L., Wu, J., Long, Y., Tao, J., Xu, J., Yuan, X., Yu, N. H., Wu, R., & Zhang, Y. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2332-z · Cited by 70
Plana‐Ripoll, O., Canudas‐Romo, V., Weye, N., Laursen, T. M., McGrath, J. J., & Andersen, P. K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228073 · Cited by 68
Self-citationSrivastava, A., Dada, O. O., Qian, J., Al-Chalabi, N., Fatemi, A. B., Gerretsen, P., Graff, A., & Luca, V. D. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114218 · Cited by 75
Islam, M. M., Hassan, S., Akter, S., Jibon, F. A., & Sahidullah, M. (2024) · Healthcare Analytics · doi:10.1016/j.health.2024.100350 · Cited by 89
Svensson, C. K., Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Koyuncu, K., Schjerning, O., Nielsen, J., Ekstrøm, C. T., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12982 · Cited by 66
“Patients with schizophrenia have a reduced life expectancy of 20 years compared to the background population (1).”
BackgroundTowards clinically actionable digital phenotyping targets in schizophrenia
Henson, P., Barnett, I., Keshavan, M. S., & Torous, J. B. (2020) · Schizophrenia · doi:10.1038/s41537-020-0100-1 · Cited by 59
“Schizophrenia affects nearly 20 million people worldwide and presents substantial health, social, and economic burdens due to the presence of comorbidities, long duration of illness, ever-present risk of relapse, and excess early mortality 1 – 3 .”
BackgroundHuang, C.-Y., Fang, S., & Shao, Y. J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8810 · Cited by 62
Depp, C. A., Moore, R. C., Perivoliotis, D., Holden, J. L., Swendsen, J. D., & Granholm, E. L. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.028 · Cited by 68
“Unfortunately, as noted by multiple authors (Laursen et al., 2014; Nock et al., 2008), these risk factors provide limited understanding of the mechanisms of suicidal thoughts in schizophrenia.”
BackgroundEating disorders and psychosis: Seven hypotheses
Seeman, M. V. (2014) · World Journal of Psychiatry · doi:10.5498/wjp.v4.i4.112 · Cited by 62
Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway
García‐Rizo, C., Kirkpatrick, B. W., Fernández-Egea, E., Oliveira, C., & Bernardo, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.001 · Cited by 60
“Most studies focus on a specific diagnosis of SMI (Laursen et al., 2013), while only few compare results taking SMI as a group (Druss et al., 2011; Laursen et al., 2007; Nordentoft et al., 2013).”
MacIsaac, M. B., Bugeja, L. C., & Jelinek, G. A. (2016) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12594 · Cited by 64
Butler, H., & O'Brien, A. J. (2017) · International Journal of Mental Health Nursing · doi:10.1111/inm.12360 · Cited by 60
Helleberg, M., Pedersen, M. G., Pedersen, C. B., Mortensen, P. B., & Obel, N. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00089-2 · Cited by 56
Self-citationDNA Methylation and Schizophrenia: Current Literature and Future Perspective
Magwai, T., Shangase, K. B., Oginga, F. O., Chiliza, B., Mpofana, T., & Xulu, K. R. (2021) · Cells · doi:10.3390/cells10112890 · Cited by 68
“The life expectancy of individuals with schizophrenia is reduced by 15–20 years compared to the general population [10,11].”
BackgroundLi, X., Wei, N., Song, J. G., Liu, J., Yuan, J., Song, R., Liu, L., Mei, L., Yan, S., Wu, Y., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116305 · Cited by 66
Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity
Ganeshalingam, A. A., Uhrenholt, N. G., Arnfred, S., Gæde, P., Düring, S. W., Stenager, E. N., Bünger, N., Pedersen, A. K., Bilenberg, N., & Frystyk, J. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2332 · Cited by 68
Stanton, R., Happell, B., & Reaburn, P. R. J. (2015) · International Journal of Mental Health Nursing · doi:10.1111/inm.12125 · Cited by 59
Accelerated aging in the brain, epigenetic aging in blood, and polygenic risk for schizophrenia
Teeuw, J., Ori, A. P. S., Brouwer, R. M., de Zwarte, S. M. C., Schnack, H. G., Pol, H. E. H., & Ophoff, R. A. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.04.005 · Cited by 55
Bachiller, A., Poza, J., Gómez, C., Molina, V., Suazo, V., & Hornero, R. (2014) · Journal of Neural Engineering · doi:10.1088/1741-2560/12/1/016007 · Cited by 55
“Thereby, SCH accounts for an approximately 20% decrease in life expectancy compared with the general population (Laursen et al 2013).”
BackgroundRusso, P., Prinzi, G., Proietti, S., Lamonaca, P., Frustaci, A., Boccia, S., Amore, R., Lorenzi, M., Onder, G., Marzetti, E., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.07.015 · Cited by 56
Charlson, F., Baxter, A. J., Dua, T., Degenhardt, L. J., Whiteford, H., & Vos, T. (2016) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0426-7_ch3 · Cited by 55
Pillinger, T., Osimo, E. F., de Marvao, A., Shah, M., Francis, C., Huang, J. V., D’Ambrosio, E., Firth, J., Nour, M. M., McCutcheon, R. A., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00403-5 · Cited by 53
“1 Further work is required to determine if the association between genetic risk for schizophrenia and cardiac alterations represents novel therapeutic targets for people with schizophrenia.”
BackgroundDong, M., Zeng, L., Zhang, Q., Yang, S.-Y., Chen, L., Najoan, E., Kallivayalil, R. A., Viboonma, K., Jamaluddin, R., Javed, A., et al. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.08.010 · Cited by 59
Zhou, Z., Wang, Y., Feng, P., Li, T., Tebes, J. K., Luan, R., & Yu, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.631420 · Cited by 62
“PLSs usually have reduced life expectancy in comparison with individuals from the general population (11).”
Background‘That red flag on your file’: misinterpreting physical symptoms as mental illness
Happell, B., Ewart, S. B., Bocking, J., Platania‐Phung, C., & Stanton, R. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13355 · Cited by 53
A self-learned decomposition and classification model for schizophrenia diagnosis
Khare, S. K., & Bajaj, V. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106450 · Cited by 55
Komatsu, H., Onoguchi, G., Silverstein, S. M., Jerotić, S., Sakuma, A., Kanahara, N., Kakuto, Y., Ono, T., Yabana, T., Nakazawa, T., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02340-4 · Cited by 53
DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia
McKinney, B. C., Huang, L., Ding, Y., Lewis, D. A., & Sweet, R. A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.025 · Cited by 54
“Individuals with SZ also die ~20 years prematurely (Laursen et al., 2014).”
EEG-Based Schizophrenia Diagnosis through Time Series Image Conversion and Deep Learning
Ko, D.-W., & Yang, J.-J. (2022) · Electronics · doi:10.3390/electronics11142265 · Cited by 50
“Statistics show that more than 69% of schizophrenic patients are not receiving appropriate treatment, and more than 90% of these patients live in low-income or middle-income countries with insufficient healthcare access [1,2].”
BackgroundMauriño, J., Sicras‐Mainar, A., Ruíz-Beato, E., & Navarro‐Artieda, R. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75449 · Cited by 55
“The mortality rate in patients with schizophrenia is two to three times higher than that expected in the general population, with a reduction in life expectancy of 10–25 years.(2) Increased risk of suicide, an unhealthy lifestyle, poor physical health, and side effects of antipsychotic drugs are the four main reasons…”
BackgroundBarnes, T. R. E., Bhatti, S. F., Adroer, R., & Paton, C. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007633 · Cited by 51
“INTRODUCTION People with schizophrenia have an excess mortality, 2 to 3 times higher than the general population; life expectancy is shortened by 15–20 years.(1) This differential mortality gap appears to have increased over recent decades.”
BackgroundLee, K., Abraham, S., & Cleaver, R. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.07.006 · Cited by 53
Central- and autonomic nervous system coupling in schizophrenia
Schulz, S., Bolz, M., Bär, K., & Voss, A. (2016) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2015.0178 · Cited by 47
Kishi, T., Matsunaga, S., & Iwata, N. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw043 · Cited by 54
Holt, R. I. G., Hind, D., Gossage-Worrall, R., Bradburn, M. J., Saxon, D. H., McCrone, P., Morris, T., Etherington, A., Shiers, D., Barnard-Kelly, K. D., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22650 · Cited by 51
“5) 172 (39) 136 (22) Social worker 27 (13) 29 (14) 9 (3) 4 (0.”
BackgroundMethodInfluentialOlder molecular brain age in severe mental illness
Lin, C., Chang, L., Ma, T., Oh, H., French, B. J., Puralewski, R., Mathews, F., Fang, Y., Lewis, D. A., Kennedy, J. L., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0834-1 · Cited by 52
Physical health and mental illness: listening to the voice of carers
Happell, B., Wilson, K., Platania‐Phung, C., & Stanton, R. (2016) · Journal of Mental Health · doi:10.3109/09638237.2016.1167854 · Cited by 48
“The life expectancy gap between people diagnosed with a mental illness and the general public has been described in the literature as an unacceptable health inequality that requires immediate action (Blomqvist & Ziegert, 2011; Happell et al., 2015; Laursen et al., 2014; Lawrence et al., 2013).”
Background
Metadata
- Authors
- Laursen, T. M., Nordentoft, M., & Mortensen, P. B.
- Affiliations
- Aarhus University (DK)
- University of Copenhagen (DK)
- Venue
- Annual Review of Clinical Psychology
- Publisher
- Annual Reviews
- Published
- 2014-03-28
- Volume
- 10
- Issue
- 1
- Pages
- 425-448
- ISSN
- 1548-5943 (ISSN-L)
- 1548-5951
- OpenAlex
- W2167532647
- Cited by
- 913
- References
- 132
- Citations by year
- 2026: 67 · 2025: 93 · 2024: 100 · 2023: 107 · 2022: 102 · 2021: 100 · 2020: 89 · 2019: 65 · 2018: 52 · 2017: 47 · 2016: 45 · 2015: 27 · 2014: 16
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Clinical Psychology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- Lundbeckfonden (R155-2014-1724, R155-2012-11280)
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, excess mortality, life expectancy, mortality gap, modifiable risk factors, antipsychotic adverse effects, somatic comorbidity, lifestyle factors, mortality prevention
- MeSH terms
- Accidents, Alcohol Drinking, Humans, Life Expectancy, Life Style, Mortality, Obesity, Risk Factors, Schizophrenia, Smoking, Suicide, Antipsychotic Agents, Comorbidity, Metabolic Syndrome, Health Status Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review